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Abstract 
Bacteria are known to possess various modifications on the cell envelope for a variety of reasons, 
including pathogenicity and survivability. Components on the Gram-negative bacteria cell 
envelope such as the lipopolysaccharide (LPS) and peptidoglycan, among others, are commonly 
modified in a multitude of ways. In Salmonella, the LPS itself can possess different modifications 
on the three components of the molecule; the O-antigen, core polysaccharide and lipid A. This 
study focuses on two LPS O-antigen acetyltransferases, namely OafA and GtrC family II proteins, 
which target different sugar residues within the O-antigen.  
Findings from this project suggest that OafA and GtrC family II proteins are highly similar and 
possess two domains in the form of an N-terminal inner membrane bound acyltransferase 3 
domain and a C-terminal SGNH hydrolase domain. SGNH hydrolase domains possess a 
characteristic α/β/α fold. In addition, a catalytic triad of serine, aspartate and histidine is also 
present with the latter being separated by a maximum of two amino acids (DXXH). Using the 
GtrC family II protein from the invasive non-typhoidal Salmonella (iNTS) strain S. Typhimurium 
D23580, GtrCBTP1, as a model for GtrC family II proteins, the amino acids within the catalytic triad 
were individually replaced by alanine and the functions were analyzed by phage susceptibility. 
Each of the single replacement mutations resulted in the abrogation of the protein function, 
suggesting that each of the catalytic residues tested are important for protein function.  
To further describe these acetyltransferases, biochemical and biophysical experiments would be 
performed and these methods require pure samples of proteins. This study developed a method 
for the successful expression and purification of these membrane bound acetyltransferases with 
an overall yield of approximately 1.2 mg of the purified proteins per litre of bacterial culture. 
Expression of these proteins were performed in an E. coli based expression culture using an L-
arabinose inducible vector which also introduced a deca-His tag on the C-terminal end of the 
expressed proteins. The methods described in this thesis for the expression and purification of 
OafA and GtrCBTP1 can be brought forward to aid in the preparation of these proteins for future 
biochemical and biophysical experiments. 
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1.1 Salmonella 
Gastrointestinal infections are continuously problematic across developing and also, developed 
countries (Ternhag et al., 2008). These infections are known to be caused by members of the 
enterobacteriaceae family of Gram negative bacteria which, as seen in the name of the family, 
are enteric in nature (Kauffmann, 1966). They are able to invade target host cells and, in turn, 
able to cause infections to the host, depending on their characteristics. The pathogenic groups 
of bacteria within this family include the genera Klebsiella, Escherichia and Salmonella.  
The genus Salmonella is closely related to the genus Escherichia and causes salmonellosis 
(Coburn et al., 2007). This genus is further divided to two species, namely Salmonella bongori (S. 
bongori) and Salmonella enterica (S. enterica). The latter is the better studied of the two species 
due to the association of this species to human and warm blooded animal infections, making it 
clinically significant. While many of the strains of Salmonella are incapable of being pathogenic, 
there are select strains which are major causes of food borne illnesses such as typhoid fever and 
gastroenteritis. On the other hand, S. bongori is associated with the diseases that occur within 
cold-blooded animals such as lizards (Fookes et al., 2011). The classification of the bacteria 
family Salmonella is depicted on Figure 1.1.1. 
1.1.1 Salmonella enterica 
Both species of Salmonella mentioned in Section 1.1 are able to invade host cells due to the 
presence of the Salmonella Pathogenicity Island 1 (SPI1) (Galan and Curtiss, 1989, Mills et al., 
1995). However, the presence of SPI2 encoding the type 3 secretion system 2 (T3SS-2) in S. 
enterica allows the bacteria within this family to cause enterocolitis and infect systemically. This 
species of Salmonella uses proteins secreted using the T3SS-1 and T3SS-2 proteins to cause the 
invasion into the host cells and proliferation within these cells (Bispham et al., 2001, Coombes 
et al., 2005, Coburn et al., 2005). S. enterica is further divided into 6 subspecies in S. enterica 
subsp. arizonae, diarizonae, houtenae, indica, salamae and enterica.  
1.1.2 Salmonella enterica subspecies enterica 
The S. enterica subsp. enterica is the only one of the six subspecies of S. enterica which is 
responsible for the occurrence of salmonellosis in warm blooded animals. This subspecies can 
also be referred to as Subspecies I and is further divided into serovars based on their antigenic 
properties. Over 2600 serovars of S. enterica subsp. enterica have been identified (Gal-Mor et 
al., 2014). 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.1. Classification of Salmonella bacterium. 
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1.1.3 Salmonella enterica subspecies enterica serovars 
Bacteria within the enterica subspecies of Salmonella enterica are further classified into 
serovars, depending on the antigenic structure of the bacteria. The factors that affect the 
serotyping are molecules found on the surface of the bacteria and hence, the antigenic 
properties. The Kauffman-White scheme (Microbiology, 1934) utilises the combination of the O-
antigen of the lipopolysaccharide (LPS) and the H-antigen of the flagella to classify bacteria 
within S. enterica subsp. enterica into serovars (Cdc.gov, 2015). 
Some of the clinically relevant serovars include S. enterica subsp. enterica serovar Typhi, 
Paratyphi and Typhimurium. The names of these serovars are shortened to S. Typhi, S. Paratyphi 
and S. Typhimurium respectively. The different disease outcomes would be determined by the 
host and the infecting strain of S. enterica (subspecies I) (Fierer and Guiney, 2001). 
The host adapted S. Typhi and Paratyphi are typhoidal salmonella which cause typhoid fever in 
humans (Huang and DuPont, 2005). Typhoid fever is characterised by bacteraemia which occurs 
when the bacteria which invade the gastrointestinal tract then escape into the body and blood 
stream. Other S. enterica serovars are classified as non-typhoidal Salmonella (NTS) and includes 
both pathogenic and non-pathogenic strains. S. Typhimurium, a form of pathogenic NTS, is a 
common cause of gastroenteritis in humans. Also, as seen in the name, S. Typhimurium is able 
to cause typhoid fever in mice. Despite being non-typhoidal, a few strains of NTS are also 
invasive and cause bacteraemia. These strains of NTS are collectively referred to as invasive non-
typhoidal salmonella (iNTS) (Gordon, 2011). 
1.2 Cell Components of Gram Negative Bacteria including Salmonella 
Bacteria have an overall structure of one or two membranes surrounding the cytoplasm which 
contains the genome and various cytoplasmic proteins and enzymes (Figure 1.2.1). Bacteria are 
classified as either Gram-positive or Gram-negative based on the thickness of the peptidoglycan 
and the absence or presence of an outer membrane (Hucker and Conn, 1923). This classification 
is based on the Gram staining of the bacteria using crystal violet staining and counter staining. 
Gram-positive bacteria such as Staphylococcus and Bacillus have thick peptidoglycan layers 
while gram-negative bacteria such as Escherichia and Salmonella have a thin peptidoglycan layer 
surrounded by an outer membrane. 
1.2.1 Gram-negative bacteria cell envelope 
The cytoplasm of the Gram-negative bacteria is surrounded by a cell envelope which consists of 
the inner membrane and the cell wall, which is made up of the peptidoglycan layer and the outer 
membrane (Wilson et al., 2011). The inner membrane and the outer membrane are made up of 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.1. Structure of the Gram-Negative Bacteria. The composition of the inner membrane and the cell wall is depicted inset. 
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lipid bilayers and can possess various bound proteins and molecules which perform a range of 
functions. Along with the peptidoglycan, these proteins and other molecules were discussed in 
Section 1.2.1.1 to 1.2.1.3. 
1.2.1.1 Membrane proteins, lipoproteins and periplasmic proteins 
A vast number of proteins exist within the bacteria’s cell wall and inner membrane. These 
proteins can be transmembrane proteins, lipoproteins and periplasmic proteins (Wilson et al., 
2011). Transmembrane proteins span the entire width of the membrane and could also include 
a hydrophilic periplasmic or cytoplasmic domain. Lipoproteins contain a lipid domain which 
anchors the protein, while allowing the hydrophilic domain to perform the protein function. 
Lastly, periplasmic proteins are soluble proteins found in the periplasm.  
These proteins are functionally important to ensure bacterial survivability and in some cases, 
pathogenicity. Examples of these proteins are the inner membrane bound cell wall modifying 
enzymes and the outer membrane bound β-barrel shaped porins which allows for the transport 
of molecules across the lipid bilayer.  
1.2.1.2 Peptidoglycan  
The peptidoglycan of bacteria is a structurally important feature of the cell wall in order to 
maintain cell structure integrity (Höltje, 1998). As mentioned in Section 1.2, Gram-positive 
bacteria have a thick peptidoglycan layer while Gram-negative bacteria have a thinner 
peptidoglycan layer, surrounded by a lipid bilayer outer membrane (Figure 1.2.1). The 
peptidoglycan is formed from layers of polysaccharides made up of alternate N-acetylmuramic 
acid (MurNAc) and N-acetylglucosamine (GlcNAc) molecules (Figure 1.2.2). Each MurNAc 
molecule possesses a short 4 amino acid tail which, with the help of transpeptidase, are cross 
linked with the amino acid tail of another MurNAc. 
The peptidoglycan is a common target for bactericidal β-lactam antibiotics such as penicillin and 
cephalosporins which act by inhibiting the formation of the peptidoglycan and hence, affecting 
the cell wall integrity (Morin and Gorman, 2014).      
1.2.1.3 Lipopolysaccharide – S. Typhimurium 
The lipopolysaccharide (LPS) is a polysaccharide molecule found in abundance on the outer 
membrane of Gram-negative bacteria. These molecules have multiple functions for bacterial 
survival and pathogenicity. They are made up of lipid A, the core polysaccharide and the O-
antigen (Erridge et al., 2002). Using the S. Typhimurium LPS as an example, the structure of the 
LPS is depicted on Figure 1.2.3.
20 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.2. Structure of the Peptidoglycan. N-acetylglucosamine (NAG) molecules were represented by green hexagons. N-acetylmuramic acid (NAM) molecules 
were represented by orange hexagons and the 4 amino acid long tails were represented in a chain of 4 black circles. Cross linking of these amino acid chains between 
the layers were identified. Structural information were attained from Boneca (2005). 
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Figure 1.2.3. Structure of the Unmodified S. Typhimurium (1,4,12:i:1,2) Lipopolysaccharide 
(LPS). The different components of the LPS (i.e. Lipid A, Core Polysaccharide and O-antigen) were 
identified by their respective names in bold with a coloured brace. The linkages of the different 
sugar residues within the O-antigen were also presented as identified by the black dotted arrow.           
3-deoxy-D-mannooctulosonic acid (KDO), galactose (Gal), heptose (Hep), glucose (Glc) 
rhamnose (Rha), mannose (Man), abequose (Abe). Structural information were attained from 
Miller et al. (2005). Diagram designed using ChemSketch v14.01.
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Lipid A anchors the LPS molecule in the lipid bilayer of the outer membrane and provides the 
toxicity of the LPS. Using the lipid A tail, the LPS is able to cause the triggering of the immune 
system by activating the human pathogen-associated molecular patterns (PAMPs) receptor, 
Toll-like receptor 4 (TLR4), when in abundance in the blood stream (Miller et al., 2005). This 
endotoxemia can cause septic shock (Raetz and Whitfield, 2002).   
The O-antigen subunits differ between different serovars of Salmonella and other bacteria. In 
the case of S. Typhimurium, the basal O-antigen subunit shown on Figure 1.2.3 is made up of an 
α-D-mannose joined via a (1-4) linkage to an α-L-rhamnose which is also joined with an α-D-
galactose via a (1-3) linkage (Hellerqvist et al., 1968). The α-D-mannose is also bound to an α-D-
abequose the with a (3-1) linkage. This forms one O-antigen subunit which is linked to another 
O-antigen subunit via a (1-2) linkage from the α-D-galactose from one O-antigen subunit to the 
α-D-mannose of another O-antigen subunit. The unmodified form of the LPS O-antigen forms 
the O:4 serotype in the presence of the abequose residue (Grimont and Weill, 2007). On the 
other hand, the O:12 serotype is the result of the absence of modifications and the abequose 
residue on the LPS O-antigen. 
The makeup of the components of the LPS can vary between different bacteria. These include 
the use of a combination of different saccharide molecules to create the LPS backbone and the 
presence of different modifications on the LPS structure. LPS structure modifications will be 
discussed in Section 1.3. Some pathogenic bacteria, namely Neisseria and Haemophilus, possess 
the lipooligosaccharide (LOS) rather than the LPS. This molecule is defined as a low molecular 
weight LPS, possessing only the lipid A and core oligosaccharides, which mimics host proteins. 
(Moran et al., 1996). 
1.3 Modifications Within Components in the Cell Wall 
To ensure survivability, the various components of the cell wall can be modified. The 
peptidoglycan, flagella and the LPS can be modified in multiple ways. For this thesis, the 
modifications of the LPS will be focused on and discussed further. Using the S. Typhimurium LPS 
as a model, the LPS structure with the respective modifications was depicted on Figure 1.3.1 
which can be compared to the unmodified LPS structure shown on Figure 1.2.3. 
1.3.1 LPS modifications 
1.3.1.1 Lipid A and core polysaccharide modifications 
Multiple modifications of the Lipid A and the core polysaccharide in S. Typhimurium are 
regulated by the two component regulatory systems in PhoP-PhoQ and PmrA-PmrB (Miller et 
al., 2005). PagL and PagP are two modification enzymes regulated by PhoP-PhoQ which 
deacylates lipid A and transfers a palmitate to lipid A respectively 
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Figure 1.3.1. Structure of the S. Typhimurium LPS with modifications. PhoP-PhoQ mediated 
modifications were coloured in red. PmrA-PmrB mediated modifications were coloured in green. 
O-antigen modifications were colour coded in either blue, purple or orange and in bold. A 
diagram showing the O-antigen modifications was identified with a dotted arrow. 3-deoxy-D-
mannooctulosonic acid (KDO), galactose (Gal), heptose (Hep), glucose (Glc), rhamnose (Rha), 
mannose (Man), abequose (Abe). Structural information were attained from Hellerqvist et al. 
(1968), Miller et al. (2005) and Kintz et al. (2015). Diagram designed using ChemSketch v14.01. 
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(Guo et al., 1998, Trent et al., 2001). LpxO is also a PhoP-PhoQ regulated enzyme which transfers 
a hydroxyl group to a lipid A tail (Gibbons et al., 2000). These modifications alter lipid A 
recognition by human TLR4. PmrA-PmrB regulates a set of enzymes that confer increased 
resistance to cationic antimicrobial peptides such as polymyxin. These enzymes can modify the 
LPS by the addition of 4-aminoarabinose (Ara4N) or phosphoethanolamine to different sites on 
lipid A and core polysaccharide.   
1.3.1.2 O-antigen modifications 
As discussed in Section 1.1.3, the O-antigen of the LPS and the H-antigen of the flagella are used 
to determine the serotype of the Salmonella in the Kauffman-White classification. Multiple 
modifications on the S. Typhimurium LPS O-antigen subunits are known and produce different 
serotypes. Glucosylation of the galactose residue is a form of modification which could be 
present and are thought to be caused by the activity of the gtr operon (Davies et al., 2013). 
Acetylation of the O-antigen subunit of the S. Typhimurium LPS is of particular interest in this 
project with this modification known to exist on abequose (Abe) (Hellerqvist et al., 1968) and 
rhamnose (Rha) (Wollin et al., 1987; Micoli et al., 2014). These O-antigen modifications will be 
further discussed in Section 1.4. 
1.4 O-antigen Modifications in S. Typhimurium 
1.4.1 Glucosylation - Gtr operon 
Glycosylation of the O-antigen subunit is caused by proteins from the gtr operon. This operon 
typically encodes for three Gtr proteins, namely GtrA, GtrB and GtrC (Davies et al., 2013). These 
three proteins are inner membrane bound and act as a mechanism for the addition of the sugar 
to the O-antigen. Using studies from the Shigella flexneri gtr operon, the GtrA and GtrB proteins 
are responsible for the transfer of the glucose from the cytoplasm, across the inner membrane 
and into the periplasm where the GtrC then adds this sugar onto the O-antigen (Allison and 
Verma, 2000). 
Davies et al. (2013) performed phylogenetic analyses of the gtr operons found in Salmonella 
(Figure 1.4.1). 10 GtrC, 7 GtrB and 5 GtrA clusters were identified in the different strains of 
interest and each strain can possess more than one form of the gtr operon. Comparing the 
amino acid identities between each of the clusters of the Gtr proteins separately, it was 
determined that the GtrC clusters are the most significantly different and the identities between 
the GtrA at 84% and GtrB at 90% are significantly higher. The significant differences between 
the GtrC clusters suggest that the differences between the serotypes in S. enterica (subspecies 
I) might be a result of the various GtrC protein activities. These clusters of GtrC will, henceforth, 
be individually referred to as a GtrC family and each family assigned a roman numeral. Within 
the GtrC families for S. enterica (subspecies I), strains possessing family I to IV are not confined 
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within one serogroup which is a group of serotypes with common antigens. This could mean 
that the different families mentioned are responsible for different O-antigen modifications.   
1.4.1.1 Family I and III and Family IV 
Consistent with the glycosyltransferase activity, both GtrC Family I and III were determined to 
facilitate the addition of a glucose to the galactose moiety of the O-antigen backbone with a     
(1-6) linkage to give the O:1 serotype (Young et al., 1964, Vander Byl and Kropinski, 2000, Pedulla 
et al., 2003) and (1-4) linkage to give the O:122 serotype respectively (Bogomolnaya et al., 2008). 
This modification is shown on the modified S. Typhimurium O-antigen subunit shown on Figure 
1.3.1. 
P22 is a phage which also possesses a gtr operon with GtrC family I. Prior to infection, the P22 
phage is able to cleave the LPS O-antigen of the target cell using the endorhamnosidase activity 
of the tailspike protein in order to improve the phage’s access to the surface of the bacteria. The 
formation of the O-antigen of the O:1 serotype, caused by GtrC family I, inhibits the 
endorhamnosidase activity (Figure 1.4.1). On the other hand, the O:122 serotype, caused by GtrC 
family III, is not able to block the endorhamnosidase activity (Wollin et al., 1981, Svenson et al., 
1979). This suggests that S. enterica strains possessing the O:1 serotype could have acquired gtr 
operon from the P22 phage in order to avoid multiple infections within the same host cell, 
defined as superinfections. 
1.4.1.2 Family IV 
To date, the function of GtrC family IV has yet been characterised. An LPS band profiling was 
performed by Davies et al. (2013) using TSDS-PAGE separation of the samples of LPS from a wild 
type strain of S. infantis, another with an unmodified O-antigen and another complemented 
with a plasmid expressing GtrC family IV from a constitutive promoter to determine if any 
glucosylation occurs. Glucosylation would increase the mass of the LPS bands and would appear 
at a higher molecular weight on the gel. However, this outcome was not observed for the 
complemented strain of S. infantis. Hence, the function of the GtrC family IV would likely to not 
be glucosylation.   
1.4.1.3 Family II – GtrCBTP1and the BTP1 phage 
Davies et al. (2013) identified that family II gtr operons possess a truncated or absent gtrB gene 
with a truncated gtrA gene. This suggests that GtrA and GtrB might not be necessary for the 
function of GtrC unlike that of family I and III where GtrA and GtrB are required for the transport 
of the glucose for the addition onto the galactose moiety. An LPS band profiling detecting the 
band shifts as mentioned in Section 1.4.1.2 was also used to assess the outcome of the 
expression of GtrC family II and like GtrC family IV, no shifts were observed and hence, no 
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Figure 1.4.2. Infection of Bacteria by Bacteriophages. Bacteria with an unmodified O-antigen 
(a) are susceptible to specific bacteriophage infections. Specific LPS O-antigen modifications in 
acetylation (OAc) and glucosylation (Glc) (b) can block the ability for phages to perform LPS 
cleavage to allow for better access to the cell surface. 
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addition of glucose was thought to be present. This suggests that GtrC family II would possess 
another function.     
S. Typhimurium D23580 is a newly identified invasive non-typhoidal Salmonella (iNTS) (Kingsley 
et al., 2009) which possesses a glucosylation modification on the galactose residue and the 
presence of acetyl groups on the abequose and rhamnose residues of the LPS O-antigen (Figure 
1.3.1). Through genomic analysis, the family II gtr operon on the BTP1 prophage was identified 
(Davies et al., 2013, Kintz et al., 2015) . Like the P22 phage and strains of S. enterica expressing 
the GtrC family I protein, it was hypothesised that GtrC family II functions to block the BTP1 
tailspike protein mediated O-antigen cleavage by modifying the O-antigen serotype (Figure 
1.4.1). From here henceforth, GtrC family II protein of S. Typhimurium D23580 will be referred 
to as GtrCBTP1. Kintz et al. (2015) performed a BLAST analysis of GtrCBTP1 and identified one 
Shigella flexneri O-antigen acetyltransferase called Oac and a S. Typhimurium LPS O-
acetyltransferase called OafA. The latter is responsible for the acetylation of the abequose 
residue of the LPS O-antigen of S. Typhimurium to give the O:5 antigen (Slauch et al., 1995, 
Slauch et al., 1996). This protein will be discussed further in Section 1.4.2. 
Through bioinformatics, protein analysis and comparisons with the S. flexneri Oac and S. 
Typhimurium OafA, Kintz et al. (2015) suggested that GtrCBTP1 is an acetyltransferase. GtrCBTP1 
was predicted to possess 11 transmembrane domains and a C-terminal periplasmic tail which is 
273 amino acids long with similar characteristics with O-antigen acetyltransferases discussed 
above. Strains of S. Typhimurium deficient of GtrCBTP1 was susceptible to BTP1 phage associated 
lysis as determined using a phage assay. GtrCBTP1 was able to function on its own in the absence 
of GtrA and GtrB. Using the biochemical analysis of the LPS O-antigen of S. Typhimurium D23580 
by Micoli et al. (2014), data from Kintz et al. (2015) suggests that GtrCBTP1 is responsible for the 
acetylation of the rhamnose residue.        
1.4.2 OafA 
The acetylation on the abequose residue of the S. Typhimurium LPS O-antigen is thought to be 
caused by a putative acetyltransferase protein called OafA producing the O:5 serotype (Slauch 
et al., 1995; Slauch et al., 1996). The presence of acetylation on the abequose residue was 
immunologically significant to the bacteria and host but is not important to the virulence of the 
bacteria (Michetti et al., 1992, Michetti et al., 1994). This protein was predicted to possess 9 
transmembrane helices with a C-terminal tail. Despite being extensively biologically 
characterised, the molecular basis of OafA has yet to be characterised.  
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1.5 Aim of the Project 
Comparing OafA to GtrCBTP1, very similar characteristics were observed in their structure and 
function. Both proteins were thought to be membrane bound with a C-terminal periplasmic tail 
with the predicted ability to add an acetyl group to a sugar residue of the LPS O-antigen of 
various S. enterica strains. The main difference between these proteins is the sugar substrate 
specificity with abequose for OafA and rhamnose for GtrCBTP1.  
The aim of this project is to characterise OafA and GtrCBTP1 using various bioinformatical, 
microbiological and biochemistry methods. It was hypothesised that OafA and GtrCBTP1 are 
closely related both structurally and functionally. However, it was predicted that differences 
would lie in their respective substrate binding sites. To understand OafA and GtrCBTP1, functional 
and in-depth bioinformatics analysis of these proteins were performed followed by appropriate 
in vivo and in vitro assays to support the bioinformatical findings.
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2.1 Bacterial Strains, Plasmids and Oligonucleotides  
Each item mentioned on Tables 2.1.1 to 2.1.4 was identified by a specific code and the 
description was included.  
Table 2.1.1 and 2.1.2 respectively contains the list of E. coli and Salmonella used in this project 
sorted according to genus and whether they are harbouring a plasmid. 
Table 2.1.3 contains the list of plasmid vectors used. 
Table 2.1.4 contains the list of oligonucleotides used. They are sorted according to which 
experiments they are used in or if they are sequencing primers. 
2.2 Products  
2.2.1 Chemicals and kits 
The kits used for DNA preparation (i.e. the QIAprep Spin Miniprep kit, the QIAquick PCR 
Purification Kit, QIAEX II Gel Extraction Kit and the QIAquick Gel Extraction Kit) were purchased 
from Qiagen.  
Other chemicals and reagents were acquired from Fisher Scientific, Sigma Aldrich, Life 
Technologies, Melford, VWR international, Merck-Millipore and Bio-Rad, among others. 
2.2.2 Molecular biology reagents 
Two commercially available chemically competent strains of E. coli were used in this project. 
These were the E. cloni® 10G Chemically Competent Cells (Lucigen) and the XL1-Blue Competent 
Cells (Agilent). 
Enzymes and other biological agents were attained from New England Biolabs (NEB), Qiagen, 
Sigma-Aldrich, Promega, Roche and Merck-Millipore.  
2.3 In silico  
Bioinformatics analyses were mainly performed using the Geneious Basic 5.6.7 bioinformatics 
suite. 
2.3.1 Data mining 
Nucleotide and amino acid sequences were attained from NCBI using the NCBI search function 
on Geneious Basic 5.6. Protein domain searches were performed using InterPro (Available at: 
www.ebi.ac.uk/interpro/) using the amino acid sequences attained from NCBI. Protein crystal 
structures were attained from the RCSB Protein Data Bank (Available at: www.rcsb.org). 
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Table 2.1.1. List of E. coli strains used in this study. 
Name 
Strain 
Code 
Genotype 
Plasmid 
Harboured 
Source 
Wild-type E. coli strains used 
E. coli DH5α DL433 
F- endA1 glnV44 thi-1 recA1 
relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ– 
- 
Life 
Technolo
gies 
E. coli MC1061 MV1651 
F- Δ(ara-leu)7697 
[araD139]B/r Δ(codB-lacI)3 
galK16 galE15 λ- e14- mcrA0 
relA1 rpsL150(strR) spoT1 
mcrB1 hsdR2(r-m+) 
- 
(Casadab
an and 
Cohen, 
1980) 
E. coli XL-1 Blue 
(commercially 
prepared, 
chemically 
competent cells) 
- 
F- endA1 glnV44 thi-1 recA1 
relA1 gyrA96 deoR nupG 
Φ80dlacZΔM15 Δ(lacZYA-
argF)U169, hsdR17(rK
- mK
+), λ– 
- Agilent 
E. coli strains harbouring plasmids 
E. coli DH5α pOafA MV1634 See above pMV433 This study 
E. coli DH5α pOafA 
(C-tail) 
MV1636 See above pMV444 This study 
E. coli XL-1 Blue 
pGtrCBTP1 
MV1635 See above pMV434 This study 
E. coli DH5α 
pGtrCBTP1 (C-tail) 
MV1637 See above pMV445 This study 
E. coli MC1061 
pOafA 
MV1644 See above pMV433 
This 
Study 
E. coli MC1061 
pGtrCBTP1 
MV1645 See above pMV434 
This 
Study 
 
Table 2.1.2. List of Salmonella strains used in this study. 
Name 
Strain 
Code 
Genotype 
Plasmid 
Harboured 
Source 
Wild-type Salmonella strains used 
STM LT2 sMV346 
Salmonella Typhimurium LT2 
(ATCC strain number 19585, 
Lot number 215096) 
- ATCC 
STM D23580 sMV189 WT (Kingsley et al., 2009) - 
Sanger 
Institute 
Salmonella strains harbouring plasmids 
STM LT2 pGtrCBTP1 sMV888 WT pMV434 
This 
study 
STM LT2 pGtrCBTP1 
(S430A) 
sMV890 WT pMV437 
This 
study 
STM LT2 pGtrCBTP1 
(D618A) 
SMV889 WT pMV438 
This 
study 
STM LT2 pGtrCBTP1 
(H621A) 
sMV892 WT pMV439 
This 
study 
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Table 2.1.3. List of plasmids use in this study. 
Name Description 
Antibiotic 
Resistance 
Cassette 
Plasmid 
Code 
Primers used to 
Generate Inserts 
Source 
Expression vectors used 
pBADcLIC2005 
Expression 
vector, encodes 
for a C-terminal 
deca-His tag 
Ampr pMV432 - 
(Geertsma 
and 
Poolman, 
2007) 
Expression vectors with various inserts 
pOafA 
pMV432, with an 
oafA gene insert 
Ampr pMV433 
oMV1074 
+ 
oMV1075 
This study 
pOafA (C-tail) 
pMV432, with an 
oafA insert 
containing the 
sequence 
encoding the C-
terminal tail only 
Ampr pMV444 
oMV1076 
+ 
oMV1075 
This study 
pGtrCBTP1 
pMV432, with an 
gtrCBTP1 gene 
insert 
Ampr pMV434 
oMV1077 
+ 
oMV1079 
This study 
pGtrCBTP1 
(C-tail) 
pMV432, with an 
gtrCBTP1 insert 
containing the 
sequence 
encoding the C-
terminal tail only 
Ampr pMV445 
oMV1078 
+ 
oMV1079 
This study 
pGtrCBTP1 
(S430A) 
pMV432, with an 
gtrCBTP1 insert 
possessing the 
nucleotide 
changes resulting 
in an S430A 
mutation 
Ampr pMV437 
oMV1158 
+ 
oMV1159 
This study 
pGtrCBTP1 
(D618A) 
pMV432, with an 
gtrCBTP1 insert 
possessing the 
nucleotide 
changes resulting 
in an D618A 
mutation 
Ampr pMV438 
oMV1156 
+ 
oMV1157 
This study 
pGtrCBTP1 
(H621A) 
pMV432, with an 
gtrCBTP1 insert 
possessing the 
nucleotide 
changes resulting 
in an H621A 
mutation 
Ampr pMV439 
oMV1154 
+ 
oMV1155 
This study 
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Table 2.1.4. List of oligonucleotides/primers used in this study. 
Primer 
Code 
Sequence (5’ to 3’) Direction Purpose 
Protein expression - LIC 
oMV1074 
ATG GGT GGT GGA TTT GCT ATG 
ATC TAC AAG AAA TTC AGA C 
F 
Isolate the oafA gene, 
introduce LIC cassette 
oMV1076 
ATG GGT GGT GGA TTT GCT ATG 
ACA AAA GGT GTT AGT TTT AG 
F 
Isolate the oafA gene 
encoding the C-terminal 
tail only, introduce LIC 
cassette 
oMV1075 
TTG GAA GTA TAA ATT TTC TTT 
TGA AAT CTG CTT TTT CAC 
R 
Isolate the oafA gene 
(encoding both the full 
length protein and C-
terminal tail only), 
introduce LIC cassette 
 
oMV1077 
ATG GGT GGT GGA TTT GCT ATG 
GAA CAC TTA AAA TAC AGA C 
F 
Isolate the gtrCBTP1 gene, 
introduce LIC cassette 
oMV1078 
ATG GGT GGT GGA TTT GCT ATG 
GGA ATT AAA GAA AGA AGC GTA 
AAC 
F 
Isolate the gtrCBTP1 gene 
encoding the C-terminal 
tail only, introduce LIC 
cassette 
oMV1079 
TTG GAA GTA TAA ATT TTC TCT 
TAT TAT CAA ATG CCC TAT C 
R 
Isolate the gtrCBTP1 gene 
(encoding both the full 
length protein and C-
terminal tail only), 
introduce LIC cassette 
Mutagenesis 
oMV1154 
AGA TTG GGG CGC TTT GAC AAA 
GCC TG 
F 
Introduce the H621A 
mutation to the GtrCBTP1 
protein expressed from 
the pGtrBTP1 vector. 
Mutagenesis carried out 
by inverse PCR and blunt 
end ligation 
oMV1155 ACA GCT GTA ACA AAA TCT G R “ 
 
oMV1156 ACA GCT GTA GCT TGG GGC CAT F 
Introduce the D618A 
mutation to the GtrCBTP1 
protein expressed from 
the pGtrBTP1 vector. 
Mutagenesis carried out 
by inverse PCR and blunt 
end ligation 
oMV1157 AAC AAA ATC TGG GCC ATC AC R “ 
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Primer 
Code 
Sequence (5’ to 3’) Direction Purpose 
Mutagenesis (cont’d) 
oMV1158 AAT CGG TGA TGC ATA TGC AGC F 
Introduce the S430A 
mutation to the GtrCBTP1 
protein expressed from 
the pGtrBTP1 vector. 
Mutagenesis carried out 
by inverse PCR and blunt 
end ligation 
oMV1159 
ATA AAA ATA TTA TTG CGG CTA 
TTT TTA ATG 
R “ 
Sequencing 
oMV1160 
CAA AAG TGT CTA TAA TCA CGG 
CAG 
F 
Verification of gene 
inserts in the 
pBADcLIC2005 vector 
oMV1161 
ATC CGC CAA AAC AGC CAA GCT 
G 
R “ 
 
oMV966 GGC CAA GCT ATT CAG CAC TC F 
Verification of the oafA 
gene 
oMV967 GCA ATA CGG CCT GTC ATC TT R “ 
 
oMV616 
AAT CGC CAA TAC TAA TGC CAG 
C 
R 
Verification of the 
gtrCBTP1 gene 
oMV617 
TGT TGC ACC TTT GGT CTT TAG 
G 
F “ 
 
All primers used in this study were designed and then, purchased in the freeze dried form from 
Sigma-Aldrich. Stocks of primers were in 100 μM concentration. 
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2.3.2 Sequence alignments 
Nucleotide and amino acid sequence alignments were performed using the Geneious Alignment 
tool of the Geneious Basic 5.6.7 bioinformatics suite.  
For nucleotide alignments, the following parameters were set as follows. Cost matrix at 65% 
similarity (5.0/-4.0), gap open penalty at 12, gap extension penalty at 3 using the global 
alignment with free end gaps alignment type.  
For the amino acid alignments, the following parameters were set as follows. Cost matrix at the 
Identity setting, gap open penalty at 5, gap extension penalty at 0, using the global alignment 
with free end gaps alignment type.  
2.3.3 Structural analyses and predictions 
In this study, the structure of various proteins were predicted for their characterisation. These 
predictions were used to determine potential protein domains and active sites by comparing 
with known structures of various proteins derived from the literature and accessed from RCSB 
Protein Data Bank (Available at: www.rcsb.org). 
2.3.3.1 Transmembrane helix predictions 
Transmembrane helix predictions were performed using TMHMM Server v2.0 (Available at: 
www.cbs.dtu.dk/services/TMHMM/). 
2.3.3.2 3D structural predictions 
3D structural predictions were performed using SWISS-MODEL (Available at: 
swissmodel.expasy.org/). Amino acid sequences from the proteins to be predicted that were 
attained from data mining (Section 2.3.1) were threaded through the SWISS-MODEL server and 
modelled using a known protein structure as a template. 
2.3.3.3 Structural visualisation 
Protein structures, predicted or known, were attained in the PDB format (.pdb) and visualised 
on the Swiss-PdbViewer v4.1.0. 
2.4 Common Materials and Methods 
2.4.1 Bacterial Culturing – Liquid and Solid Media 
Bacteria cultures were prepared using Lennox broth (Fisher Scientific). Liquid media were 
prepared by dissolving the Lennox broth (LB) powder in ddH2O at a concentration of 20 g/L. If 
LB agar plates were to be prepared, granulated agar (Fisher Scientific) were added to the liquid 
culture mix at 17.5 g/L.   
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Both mixes were autoclaved prior to use. For solid media, the molten LB agar mix were cooled 
to 55°C and poured onto petri dishes. 
If antibiotics were required for selection, the appropriate antibiotics (e.g. ampicillin (Sigma-
Aldrich)) were added to a volume of liquid media prior to bacteria culturing or to the molten LB 
agar prior to the preparation of the LB agar plates. In this project, only ampicillin was used and 
was added to the liquid media at a final concentration of 100 μg/mL. 
Bacterial culture incubation was performed in specific temperature incubators with liquid 
cultures being grown using an orbital shaker.  
2.4.2 Genomic DNA isolation 
Bacterial strains of interest were grown to saturation using liquid media (Section 2.4.1). Next, 
1.5 mL of the culture was centrifuges for 2 minutes at 13,000 rpm in the Heraeus™ Pico™ 
microcentrifuge. The supernatant was then removed. The remaining pellet was resuspended in 
400 μL of salt homogenising buffer (final concentrations 0.4 M NaCl, 10 mM Tris-HCl pH 8.0, 2 
mM EDTA pH 8.0). 40 μL of 20% SDS (Melford) and 4 μL Proteinase K (Roche) at 200 μg/mL were 
added to the resuspended bacterial pellet. The mix was then incubated at 55°C overnight. The 
next day, 300 μL of 5M NaCl was added and the resulting mixture was vortexed for 30 seconds. 
After which, the mixture was centrifuged at 10,000 rpm using the microcentrifuge for 30 
minutes. The supernatant was separated from the pellet which contains the bacterial cell wall 
debris. An equal amount of isopropanol (Sigma-Aldrich) was mixed well with the supernatant 
before incubation at -20°C for 1 hour. After incubation, the mixture was centrifuged for 20 
minutes at 10,000 rpm at 4°C in the Eppendorf Centrifuge 5415 R microcentrifuge. The 
supernatant was thoroughly pipetted out, leaving a pellet. The pellet containing the gDNA was 
washed in 70% ethanol (AnalaR NORMAPUR) and then sufficiently dried before resuspension in 
autoclaved ultrapure water (Milli-Q by Millipore Corporation). The resuspended gDNA was 
further incubated at 65°C for 1 hour to complete resuspension. When required, storage of the 
gDNA was performed at 4°C. 
 
2.4.3 Plasmid DNA isolation 
Bacterial strains possessing the plasmid of interest were grown to saturation in liquid culture 
(Section 2.4.1) overnight at an appropriate temperature and with appropriate antibiotics. 
Plasmid isolation was performed using the QIAprep Spin Miniprep kit (Qiagen) according to the 
protocol provided in the QIAprep Miniprep Handbook (Available at: www.qiagen.com). 
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2.4.4 Polymerase Chain Reaction (PCR) and purification 
PCR were performed on either isolated gDNA (Section 2.4.2) or plasmid DNA (Section 2.4.3). 
Primers were designed and then, ordered from Sigma-Aldrich. Primers were delivered in the 
freeze dried form and solubilised with ultrapure H2O (MilliQ by Millipore). 
 High fidelity PCR was performed using the Q5® Hot Start High-Fidelity DNA Polymerase (NEB) 
or the KOD Hot Start DNA Polymerase (Merck-Millipore). Otherwise, analytical PCR was 
performed using the GoTaq® or GoTaq® G2 Flexi DNA polymerase (Promega). For details, see 
product specific protocols which are available online. 
PCR purification was performed using the QIAquick PCR Purification Kit (Qiagen). For full 
protocol, refer to the QIAquick Spin Handbook (Available at: www.qiagen.com). 
2.4.5 DNA concentration – vacuum concentration 
DNA concentration was performed using the miVac DNA Concentrator (Genevac). Prior to DNA 
concentration, the machine was pre-warmed to 50°C. Concentration was performed at 50°C for 
an appropriate amount of time. 
2.4.6 Restriction enzyme digest 
In this project, all restriction enzyme mediated DNA digestion were performed using a single 
enzyme in each experiment. All restriction enzymes were procured from NEB and used according 
to the suppliers recommended protocol (Available at: www.neb.com). 
2.4.7 DNA analyses 
2.4.7.1 Agarose gel electrophoresis 
For DNA analyses, 0.8% or 1% agarose gels were prepared by dissolving 0.8% or 1% (w/v) 
Agarose (Sigma-Aldrich) into TAE buffer (Life Technologies). Ethidium Bromide was added to the 
mixture at a final concentration of 0.2 µg/mL . Once the gel has been solidified in a cast, the gel 
was placed in a gel electrophoresis tank filled with TAE buffer. DNA samples and the DNA 
reference ladder marker, GeneRuler DNA Ladder Mix (Thermo Scientific), were then loaded and 
gel electrophoresis was performed at 100 V. The resulting gel was visualised in a G:BOX gel doc 
(Syngene).  
2.4.7.2 DNA concentration measurement 
Measurement of DNA concentration was performed using the NanoDrop 1000 (Thermo 
Scientific). The absorbance at 260 nm were measured to determine the concentration of the 
DNA in the test sample. The 260/230 and 260/280 ratios were also analysed to determine the 
purity of the test sample. 
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2.4.7.3 Sequencing 
Sequencing was carried out by Eurofins Genomics using the SmartSeq kit using a primer specific 
to the region of DNA that is of interest. Sequencing primers were mentioned in Table 2.1.4 under 
the section of the table referred to as “Sequencing”. 
2.4.8 Gel Excision 
To isolate DNA of interest from unwanted DNA, gel excision was performed using 0.8% agarose 
gels prepared as mentioned in Section 2.4.7.1. However, ethidium bromide was replaced by the 
Nancy-520 dye (Sigma Aldrich) at a final concentration of 0.4 µg/mL. The DNA samples and the 
DNA reference ladder marker, GeneRuler DNA Ladder Mix (Thermo Scientific), were loaded and 
gel electrophoresis was performed at 25 V. The resulting gel was visualised on the Dark Reader 
Transilluminator (Clare Chemical) and the appropriate gel pieces which contains the DNA of 
interest were excised using a scalpel. Once isolated, the gel pieces were processed and the DNA 
contained within were isolated using either the QIAquick Gel Extraction Kit or QIAEX II Gel 
Extraction Kit (Qiagen). Refer to the QIAquick Spin Handbook and QIAEX II Handbook 
respectively for detailed protocols (Available at: www.qiagen.com).   
2.4.9 Bacterial Transformation 
2.4.9.1 Electroporation 
Bacteria strains to be used for transformation, were grown in liquid media (Section 2.4.1) 
overnight (approximately for 19 hours) to saturation at an appropriate temperature. A new 
liquid media was set up the next day and inoculated with the saturated bacteria culture at a 
1/50 to 1/100 dilution. The newly prepared liquid culture was grown to an OD600 of 0.5 at an 
appropriate incubation temperature in an orbital shaker. The OD600 value was measured using 
a Jenway 6505 spectrophotometer. Once an OD600 value of 0.5 was reached for the inoculated 
culture, between 1 to 5 mL of the culture was centrifuged for 7 minutes at 3,000 rpm at 4°C in 
the Eppendorf Centrifuge 5415 R microcentrifuge. The supernatant was pipetted out and 
discarded, leaving behind a bacterial pellet. The pellet was resuspended in 1 mL 10% (v/v) 
Glycerol and centrifuged for 7 minutes at 3,000 rpm at 4°C in the Eppendorf Centrifuge 5415 R 
microcentrifuge before the removal of the supernatant. This step was repeated twice more. 
After the final resuspension and centrifugation step, the bacterial pellet was resuspended in   
100 μL of 10% Glycerol.  
50 μL of the resuspended bacterial pellet was used for each transformation reaction along with 
either 1 μL to 5 μL of plasmid DNA (Section 2.4.3) or ligation independent cloning (LIC) mix 
(Section 2.5.1). The bacterial suspension and DNA were mixed and loaded into a Gene 
Pulser/Micropulser Electroporation Cuvette with a 0.2 cm gap width (BioRad). The cuvette was  
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Table 2.4.9. List of media mentioned in section 2.4.9 
Media Name Components at their final concentrations (Autoclaved/Filter Sterilised) 
SOC Medium 
2% Tryptone, 0.5% (w/v) Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 10 mM MgSO4 
(Autoclaved) 
+ 
20 mM D-Glucose 
(Filter Sterilised) 
 
Table 2.4.12.1 List of buffers mentioned in section 2.4.12.1 
Buffer Name 
(volume) 
Components and their respective amounts/volumes (Autoclaved/Filter 
Sterilised) 
12% Separating 
Gel 
(approx. 10 mL) 
3 mL of 40% Acrylamide/Bis-acrylamide 29:1 solution, 
2.5 mL of 1.5 M Tris-HCl at pH 8.8, 100 μL of 10% (w/v) SDS, 
4.35 mL of ddH2O 
+ 
5 μL of TEMED, 50 μL of 10% (w/v) ammonium persulphate 
4% Stacking Gel 
(approx. 5mL) 
0.5 mL of 40% Acrylamide/Bis-acrylamide 29:1 solution, 
1.26 mL of 0.5 M Tris-HCl at pH 6.8, 50 μL of 10% (w/v) SDS, 
3.16 mL of ddH2O 
+ 
5 μL of TEMED, 25 μL of 10% (w/v) ammonium persulphate 
2X Sample 
Loading Buffer 
(20 mL) 
1.2 g of SDS, 1.2 mL of 2-mercaptoethanol, 0.03 g of dithiothreitol, 
9.2 mL of glycerol, 1.2 mL of 1M Tris-HCl at pH 8.0, 
small number of flakes of bromophenol blue, ddH2O to 20 mL 
(filter sterilise) 
5X Running 
Buffer (1 L) 
15.1 g of Tris, 72 g of glycine, 950 mL of ddH2O 
(Autoclaved) 
+ 
50 mL of 10% (w/v) SDS 
(Filter Sterilise) 
 
Table 2.4.12.2. List of buffers mentioned in section 2.4.12.2 
Buffer Name 
(volume) 
Components and their respective amounts/volumes (Autoclaved/Filter 
Sterilised) 
Coomassie Brilliant 
Blue Staining 
Solution 
(1 L) 
450 mL of methanol, 2.5g of Brilliant blue R, 100 mL acetic acid, 
450 mL of ddH2O 
Coomassie 
Destaining 
Solution 
(1 L) 
100 mL of ethanol, 100 mL of acetic acid, 800 mL of ddH2O 
 
 
Table 2.4.12.3. List of buffers mentioned in this section 
Buffer Name Components at their final concentrations (Autoclaved/Filter Sterilised) 
Towbin/Transfer 
Buffer 
25 mM Tris, 192 mM glycine, 20% (v/v) methanol 
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inserted into the BioRad MicroPulser™ and electroporation was then performed according to 
the suggested settings in the MicroPulser™ Electroporation Apparatus Operating Instructions 
and Applications Guide (Available at: www.bio-rad.com). In this project, the program EC2 of the 
MicroPulser™ was used. After electroporation, the mix was supplemented with 1 mL of SOC 
media (Table 2.4.9) and allowed to recover by incubation at an appropriate temperature for 1 
hour in an orbital shaker. After recovery, 100 μL to 150 μL were plated on an LB agar plate 
containing the appropriate selection antibiotics (Section 2.4.1) which would then be allowed to 
incubate overnight at a suitable temperature. 
2.4.9.2 Chemically competent cell transformation 
Chemically competent cell transformation for commercially attained bacterial strains (Section 
2.2.2.1) were performed according to the respective manufacturer’s recommended protocol. 
Otherwise, the following protocol was performed. 
A 50 μL aliquot of chemically competent bacteria cells was thawed on ice for 30 minutes. Once 
thawed, 1 μL to 5 μL of plasmid DNA (Section 2.4.3) or ligation independent cloning (LIC) mix 
(Section 2.5.1) were added to the aliquot of bacteria cells and mixed. The mixture was left on 
ice for 30 minutes, after which, heat-shock at 42°C was performed for 1.5 minutes. 500 μL of 
SOC media (Table 2.4.9) was then added to the heat-shocked mixture, which was then allowed 
to recover by incubation at an appropriate temperature for 1 hour in an orbital shaker. After 
recovery, 200 μL were plated on an LB agar plate containing the appropriate selection antibiotics 
(Section 2.4.1) which would then be allowed to incubate overnight at a suitable temperature. 
2.4.10 Induction of protein expression 
2.4.10.1 Small scale 
Small scale induction of protein expression was performed for the protein expression steps 
mentioned in results Section 4.1, 4.2 and 5.2.  
The bacterial strain of interest was grown overnight (approximately 19 hours) with the 
appropriate antibiotics. The next day, 10 mL liquid media (Section 2.4.1) was inoculated with the 
bacterial strain of interest at a dilution of between 1/50 and 1/100 the total volume and grown 
to an OD600 of between 0.5 to 0.8 in an orbital shaker at an appropriate temperature. An aliquot 
of the bacterial culture was then removed to represent the culture of uninduced bacteria, a 
control. An appropriate concentration of inducer (e.g. L-arabinose (Sigma Adrich)) was added to 
the remaining culture. The culture was then incubated to saturation at a pre-determined 
temperature for a specified amount time. 
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2.4.10.2 Large scale 
See Section 2.8.1 for further details. 
2.4.11 Bacteria cell lysis 
2.4.11.1 BugBuster™ protein extraction reagent (Merck-Millipore) 
Several cultures of induced and uninduced bacteria strains from Section 2.4.10.1 were lysed 
using the BugBuster™ Protein Extraction Reagent (Merck-Millipore). 10X BugBuster™ Protein 
Extraction Reagent was diluted to 1X concentration using phosphate buffered saline (PBS) (Life 
Technologies). A protocol was adapted from Merck’s BugBuster™ Protein Extraction Reagent 
User Protocol as is mentioned below. The protein samples representing the different fractions 
were prepared for SDS-PAGE analysis which will be discussed in Section 2.4.12. 
1 mL of the bacteria culture was spun down at 10,000 rpm for 10 minutes using the Heraeus™ 
Pico™ microcentrifuge. The supernatant was removed and the pellet was resuspended in 1X 
BugBuster™ Protein Extraction Reagent. The mixture was places on a rotating mixer for 20 
minutes. After which, a 20 μL aliquot of the mixture was separated to represent the ‘total 
protein’ fraction.  The remaining 180 μL of the mix was centrifuged at 13,000 rpm for 5 minutes 
using the Heraeus™ Pico™ microcentrifuge. For the ‘soluble protein’ fraction, 20 μL of the 
supernatant was isolated. For the ‘insoluble protein’ fraction, the supernatant was initially 
removed, the pellet was resuspended in 180 μL PBS and 20 μL of the final resuspended pellet 
was isolated. 
2.4.11.2 Sonication 
See Section 2.8.3 for further details. 
2.4.12 Protein sample analysis 
2.4.12.1 SDS-PAGE  
The SDS-PAGE gels were prepared first. A sufficient volume of the 12% separating gel (Table 
2.4.12.1) was added first into a set up with the Bio-Rad Mini-PROTEAN® 3 Glass Plates. A layer 
of isopropanol was added to the top of the gel. The gel was allowed to polymerise and once it 
had, the isopropanol was removed and the top of the gel was rinsed with ddH2O. After which, 
an appropriate amount of the 4% stacking gel (Table 2.4.12.1) was added before placement of 
a gel comb. The gel was allowed to complete polymerisation before use. If needed, the gels were 
stored at 4°C within the plates, wrapped with a moist paper towel. 
Prior to sample loading, the sample loading buffer (Table 2.4.12.1) was added to the protein 
samples to get a final concentration of 1X. The mixture was boiled for 7 minutes before loading 
into the gel. However, samples containing membrane proteins were not boiled but instead, 
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heated to a temperature of between 55°C to 65°C for a longer period of time (approximately 20 
minutes) before loading into the gel.  
For SDS-PAGE, the Bio-Rad Mini-PROTEAN® 3 vertical or the Mini-PROTEAN® Tetra systems were 
used. The abovementioned casted gels were set up accordingly into the system. The 5X running 
buffer (Table 2.4.12.1) was diluted to 1X using ddH2O before being added in an appropriate 
amount into the system. For western blot and coomassie, 7 μL and 20 μL of the protein sample 
mix was loaded into the gels respectively. At least one lane on each gel was loaded with 7 μL of 
the protein marker, Precision Plus Protein™ Kaleidoscope™ Standards or Precision Plus Protein™ 
All Blue Standards (Bio-Rad). Gel electrophoresis was allowed to run for approximately 40 to 50 
minutes at 200 V or when the dye front has reached the bottom of the gel.  
2.4.12.2 Coomassie staining 
The gel designated for coomassie staining was removed from the glass plates and sufficiently 
rinsed with ddH2O. A small volume of coomassie brilliant blue staining solution (Table 2.4.12.2) 
was added to cover the top of the gel. Staining was performed for 1 hour on a rocker at room 
temperature. After which, the staining solution was removed and the stained gel was sufficiently 
rinsed with ddH2O. An adequate amount of the coomassie destaining solution (Table 2.4.12.2) 
was then added to the stained gel. Destaining was allowed to occur overnight (approximately 
19 hours). The gel was then visualised using the G:BOX gel doc (Syngene). 
2.4.12.3 Western transfer and antibody staining 
Western transfer was performed in either of the following two systems, the iBlot® Dry Blotting 
System (Life Technologies) or the Trans-Blot® SD Semi-Dry Transfer Cell (Bio-Rad). 
Western transfer using the iBlot® Dry Blotting System was performed with the iBlot transfer 
stack containing a nitrocellulose membrane. The recommended protocol was adhered to 
(Available at: www.lifetechnologies.com). Western transfer using the Trans-Blot® SD Semi-Dry 
Transfer Cell was performed with a Immobilon-P PVDF membrane (Merck-Millipore) and the 
transfer buffer (Table 2.4.12.3) following the manufacturer’s recommended protocol (Available 
at: www.bio-rad.com). 
After the completion of the western transfer from either of the two systems, the nitrocellulose 
or PVDF membranes were prepared for western blotting using the protocol mentioned in the 
QIAexpress Detection and Assay Handbook (Available at: www.qiagen.com). The primary 
antibody used was the Tetra·His Antibody (Qiagen) and the secondary antibody was the goat 
anti-mouse IgG with a HRP conjugate (Sigma-Aldrich). 
The western blotting of the membranes were then detected via chemiluminescent detection. 
This was performed with the Luminata Classico Western HRP substrate (Merck-Millipore) 
according to the protocol suggested by the manufacturer (Available at: 
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www.mercekmillipore.com). The results were developed in the dark room and onto an 
Amersham Hyperfilm ECL (GE Healthcare Life Sciences) film. 
2.5 Ligation Independent Cloning (LIC) 
LIC is a method of cloning which involves the insertion of a gene into an expression plasmid 
without the use of a DNA ligase. Instead, this method utilises long exposed tails (LIC tails) of 
complementary DNA from both the insert and the plasmid which binds with more strength than 
the usual complementary ends after restriction enzyme digest. After annealing, the resulting 
nick would be fixed by the host strain after transformation. 
In this project, genes of interest were cloned into the pBADcLIC2005 vector possessing regions 
of DNA flanking the insert site which are able to be converted into LIC tails. The sequences to be 
converted to the LIC tail were (5’ ATG GGT GGT GGA TTT GCT 3’) and (5’ GAA AAT TTA TAC TTC 
CAA 3’). 
In order to engineer the gene of interest with the LIC tails, forward and reverse primers were 
designed to possess a region complementary to the gene and with the remaining being the LIC 
tail sequence. High fidelity PCR (Section 2.4.4) was performed using the isolated gDNA (Section 
2.4.2) of the strain possessing the gene of interest as a template and the designed primers. The 
PCR products were then purified using the QIAquick PCR Purification (Qiagen). 
The plasmid vector, pBADcLIC2005, was isolated from the host strain using the protocol 
mentioned in Section 2.4.3. To expose the two regions of DNA which would be converted to the 
LIC tail, the plasmid DNA was digested by the SwaI restriction enzyme (NEB) using the suggested 
time-saver protocol (Available at: www.neb.com).  
At this point, both the insert and the plasmid were linear with the two regions of DNA, for the 
LIC tail, flanking the gene or the rest of the plasmid respectively. To generate the LIC tails from 
these regions of DNA, the 3’ to 5’ exonuclease activity of the T4 DNA polymerase (NEB) was 
used. 200 ng of PCR products or plasmid DNA were made up to 10 μL by direct dilution with 
ddH2O or by concentrating the DNA sample first (Section 2.4.5) if need be. The 10 μL of DNA 
sample were then mixed with 3 μL of NEBuffer 2 (NEB), 25 mM of dCTP for the sample of vector 
DNA or dGTP for the PCR products (Fermentas) and 0.5 μL of T4 DNA Polymerase (NEB).  The 
mixture was then incubated for 30 minutes in a water bath at 20°C. To stop the enzymatic 
reactions, the mixture was then treated at 75°C for 20 minutes.  
The T4 DNA polymerase treated samples of plasmid DNA and PCR products were then mixed in 
a molar ratio of 1:2 for annealing. The mixture was then incubated at 20°C in a water bath for 
10 minutes before the addition of 25 mM of EDTA. A further 10 minute incubation at 20°C was 
performed. 
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The annealing mixture was then used for transformation into either a chemically competent E. 
coli or by electroporation using the methods mentioned in Section 2.4.9. For the pBADcLIC2005 
vector, antibiotic selection was performed using ampicillin (Sigma-Aldrich) at a concentration of 
100 μg/mL.  
2.6 Site Directed Mutagenesis by inverse PCR and blunt end ligation 
To introduce specific mutations to proteins of interest, mutagenesis by inverse PCR and blunt 
end ligation was performed. This utilises expression plasmids containing the gene for the protein 
of interest and mutagenic primers. 
Firstly, divergent primers (Table 2.1.4) were designed to amplify the plasmid while also 
introducing a specific mutation by utilising a mutagenic primer containing the corresponding 
base changes. The mutation was designed to be in the middle of the mutagenic primer in order 
to maximise the binding of the primer to the template plasmid DNA. The expression plasmid 
containing the gene was purified (Section 2.4.3) from the corresponding bacterial strains. Using 
the purified expression plasmid, high fidelity PCR (Section 2.4.4) with the designed divergent 
mutagenic primers was performed. The resulting products were then purified by PCR 
purification (Section 2.4.4). 
Blunt end ligation was set up with 1 μL of purified PCR products, 2 μL of T4 DNA ligase buffer 
(NEB), 1 μL T4 DNA ligase (NEB), 1 μL of T4 Polynucleotide Kinase (NEB) and 15 μL of ddH2O. The 
mixture was allowed to incubate at 16°C overnight (approximately 19 hours). 
The ligated products were then transformed into a strain of chemically competent E. coli 
(Section 2.4.9.2) before being transformed via electroporation (Section 2.4.9.1) into a S. 
Typhimurium strain for downstream in vivo analyses. The mutant genes were confirmed by 
sequencing (Section 2.4.7.3).  
 
2.7 BTP1 phage plaque assay 
To analyse the susceptibility of a strain of Salmonella to the BTP1 phage, a phage plaque assay 
was performed.  
2.7.1 Phage stock preparation 
Phage stocks of BTP1 was attained by first culturing the S. Typhimurium D23580 strain until 
saturation (Section 2.4.1). Next, the culture was centrifuged at 10,000 rpm for 10 minutes in the 
Heraeus™ Pico™ microcentrifuge to pellet the bacteria. The phage containing supernatant was 
isolated from the pellet and a few drops of chloroform was added in order to kill any remaining 
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bacteria. When necessary, the phage stocks were diluted with PBS to the desired fold 
concentration. 
 
2.7.2 Top agar preparation 
The phage plaque assay was performed using an LB agar plate that is layered with a LB agar 
called the ‘top agar’ (final concentrations 20% Lennox Broth Powder, 0.7% Agar). 
To prepare the plate, an LB agar plate was initially prepared following the protocol mentioned 
in Section 2.4.1 with the necessary concentration of supplements (i.e. inducer and antibiotics) 
when required. For each LB agar plate, 3.5 mL of top agar was prepared, supplemented with 
inducer and antibiotics at the proper concentrations when necessary and mixed with 100 μL of 
pre-prepared saturated culture of the test bacteria strain.  The final mixture was then layered 
on the pre-prepared LB agar plate and was allowed to solidify on the existing LB agar. 
2.7.3 BTP1 phage treatment 
When the top agar layer has solidified as mentioned in Section 2.10.2, 5 μL of BTP1 phage stocks 
and dilutions were added drop wise onto the top agar layer at designated positions. The drop 
was allowed to be absorbed into the top agar layer before incubation at an appropriate 
temperature overnight (approximately 19 hours). The resulting plates were then visualised.  
 
2.8 Large scale protein expression, bacteria cell lysis and vesicle/membrane fraction 
isolation 
2.8.1 Large scale protein expression 
Large scale induction of protein expression was performed as mentioned in results Section 4.3. 
The bacterial strain of interest was grown to saturation overnight (approximately 19 hours) with 
the appropriate antibiotics. The next day, pre-warmed 625 mL liquid media in a 2 L baffled flask 
was inoculated with the bacterial strain of interest at a dilution of between 1/50 and 1/100 the 
total volume and grown to an OD600 of between 0.5 to 0.8 in an orbital shaker at an appropriate 
temperature. An aliquot of the bacterial culture was then removed to represent the culture of 
uninduced bacteria, a control. An appropriate concentration of inducer (e.g. L-arabinose) was 
added to the remaining culture. The culture was then incubated to saturation at a pre-
determined temperature for a specified amount time.  
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2.8.2 Bacterial harvest 
The bacteria cultures were allowed to reach saturation after induction. After which, the cells 
were harvested by centrifugation at 5000 rpm for 15 minutes at 4°C using the Heraeus™ 
Megafuge™ 40 centrifuge (Thermo Scientific). The supernatant was discarded and the pellet was 
resuspended in 35 mL resuspension buffer (Table 2.8.1). From here henceforth, the cells were 
kept on ice.  
2.8.3 Sonication 
For sonication, 1 mM of AEBSF (Sigma-Aldrich), 1mM MgCl2 and approximately 100 μg/mL of 
DNase I (Sigma-Aldrich) was added to the 35 mL of resuspended bacteria. The mixture was 
attached to a set up with the Misonix Sonicator 3000 Homogenizer equipped with the ½ inch 
horn. Sonication was performed at 4 W with a 3 second pulse time and a 7 second rest time for 
3 minutes in total. 
2.8.4 Vesicle isolation 
After sonication, the tube containing the sonicated bacteria suspension was kept on ice for 5 
minutes before the addition of 5 mM EDTA at pH 7.5. A low speed centrifugation of the lysate 
was performed at 13,000 rpm for 20 minutes at 4°C using the JA-25.50 rotor in the Beckman 
Avanti J-26 High Speed Centrifuge. The resulting supernatant was retained. Next, the 
supernatant was centrifuged at 40,000 rpm for 1 hour at 4°C in the Beckman L7-65 
Ultracentrifuge and the Type 70 Ti rotor. The supernatant was discarded and the pellet was 
resuspended in 10 mL resuspension buffer (Table 2.8.1). The suspension contains the 
vesicles/insoluble fraction and was distributed into 0.5 mL aliquots and snap-frozen with liquid 
nitrogen and stored in -80°C. 
 
2.9 Detergent based membrane protein solubilisation and column based immobilised 
metal affinity chromatography (IMAC) 
2.9.1 Detergent based solubilisation of membrane proteins 
Vesicles isolated as mentioned in Section 2.5.2.4 were mixed appropriately with the 
solubilisation buffer (Table 2.9.1), mixed by inversion and incubated on ice for 30 minutes. The 
mixture was then centrifuged at 53,000 rpm for 20 minutes at 4°C using the Beckman L7-65 
Ultracentrifuge and the Type 70 Ti rotor.  
2.9.2 Column based immobilised metal affinity chromatography (IMAC) 
For IMAC, the HisTrap™ HP (GE Healthcare Life Sciences) column was attached to the ÄKTA 
Prime (GE Healthcare Life Sciences) to regulate the flow rates of buffers and samples loaded.  
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Prior to IMAC, the HisTrap™ column was charged with fresh nickel (Ni2+) ions and the column 
was equilibrated with the column wash buffer (Table 2.9.1).  
The supernatant from the centrifugation step mentioned in Section 2.9.1 was then allowed to 
pass through the column. The flow through was collected and saved for western blot and 
coomassie staining analyses (Section 2.4.12). The pellet from the centrifugation step was 
resuspended in PBS in an equal volume to the supernatant and a sample was analysed by 
western blot and coomassie staining analyses (Section 2.4.12). 
The column was then washed with 20 column volumes of column wash buffer (Table 2.9.1). The 
wash through was also collected and saved for western blot and coomassie staining analyses 
(Section 2.4.12). 
The elution of the proteins were performed by passing through 1 mL of the elution buffer (Table 
2.9.1) three times. The elution fractions were collected and were analysed by western blotting 
and coomassie analyses (Section 2.4.12) along with a sample of the vesicles isolated as 
mentioned in Section 2.8.4, the resuspended pellet from the centrifugation step which 
represents the insoluble fraction, the column flow through and wash through.   
2.10 Protein purification by size exclusion chromatography (SEC) 
To further purify the samples of proteins of interest isolated by IMAC as mentioned in Section 
2.5.3.2, size exclusion chromatography (SEC) by gel filtration was performed. The HiLoad 26/600 
Superdex 200 prep grade Gel Filtration column (GE Healthcare Life Sciences) was attached to an 
ÄKTA Purifier (GE Healthcare Life Sciences) to regulate the flow of buffer and samples. The gel 
filtration column was equilibrated with the SEC buffer (Table 2.10.1) before the addition of the 
samples of proteins. After loading, the SEC buffer was allowed to flow through the column again 
until 1 column volume of buffer had flowed through. Fractions of the flow through were 
continuously collected until the flow of the SEC buffer was halted. The A280 values detected by 
the sensor attached to the ÄKTA Purifier was used to determine which fractions might contain 
the protein of interest and these fractions were analysed by coomassie analysis (Section 2.4.12).
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Table 2.8.1. List of buffers mentioned in section 2.8 
Buffer Name Components at their final concentrations (Autoclaved/Filter Sterilised) 
Potassium 
Phosphate (KPi) 
Buffer 
Add 1 M KH2PO4 (Acidic) drop wise to 1 M K2HPO4 (Basic) until pH 
reaches 7.8 
Resuspension 
Buffer 
50 mM KPi Buffer pH 7.8, 20% (v/v) glycerol 
 
Table 2.9.1. List of buffers mentioned in section 2.9 
Buffer Name Components at their final concentrations (Autoclaved/Filter Sterilised) 
Potassium 
Phosphate (KPi) 
Buffer 
Add 1 M KH2PO4 (Acidic) drop wise to 1 M K2HPO4 (Basic) until pH 
reaches 7.8 
Solubilisation 
Buffer 
50 mM KPi Buffer pH 7.8, 200 mM NaCl, 20% (v/v) glycerol, 
10 mM Imidazole, 3 mM dithiothreitol, 
0.5% (w/v) n-Dodecyl β-D-maltoside 
+ 
Vesicles (Section 2.5.1.4) 
Column Wash 
Buffer 
50 mM KPi Buffer pH 7.8, 200 mM NaCl, 20% (v/v) glycerol, 
40 mM Imidazole, 3 mM dithiothreitol, 
0.04% (w/v) n-Dodecyl β-D-maltoside 
Elution Buffer 
50 mM KPi Buffer pH 7.8, 200 mM NaCl, 20% (v/v) glycerol, 
500 mM Imidazole, 3 mM dithiothreitol, 
0.04% (w/v) n-Dodecyl β-D-maltoside 
 
Table 2.10.1 List of buffers mentioned in section 2.10 
Buffer Name Components at their final concentrations (Autoclaved/Filter Sterilised) 
SEC Buffer 
50 mM KPi Buffer pH 7.8, 200 mM NaCl, 
5 mM dithiothreitol, 
0.05% (w/v) n-Dodecyl β-D-maltoside 
 
              
 
 
 
49 
 
 
 
Chapter 3 
In silico Analyses of 
Salmonella O-antigen 
Acetyltransferases, OafA 
and GtrC family II 
 
 
50 
 
 
 
 
 
 
 
 
 
Chapter 3 Introduction 
Literature based studies identified two Salmonella lipopolysaccharide (LPS) O-antigen 
membrane bound acetyltransferases in GtrC family II proteins (Davies et al., 2013) and OafA 
(Slauch et al., 1996).  
The GtrC family II proteins are thought to acetylate the rhamnose residue of the LPS O-antigen. 
Previous studies by Kintz et al. (2015) on the GtrC family II protein of S. Typhimurium D23580, 
GtrCBTP1, revealed the importance of this protein in the acetylation of the rhamnose residue and 
hence, protection against BTP1 bacteriophage associated killing.   
OafA, on the other hand, is only found in S. Typhimurium and is thought to acetylate the 
abequose residue of the LPS O-antigen, conferring the S. Typhimurium O:5 serotype. Extensive 
microbiological and immunological studies have been performed on OafA with its function being 
linked to the adherence and invasion (Michetti et al., 1994), the structure of the LPS and the 
triggering of the immune response (Slauch et al., 1995). 
The primary function of GtrC family II proteins and OafA differ only in their substrate specificity, 
with the former being specific for the rhamnose and the latter for the abequose residue of the 
LPS O-antigen. To determine what sets these two proteins apart, in silico studies were first 
performed to determine any similarities and differences between these proteins while also 
identifying any potential associations to known protein families which would provide a better 
understanding of their respective characteristics. 
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3.1 Sequence similarities and differences between GtrC family II proteins and OafA 
To identify the similarities within the sequences of OafA and the GtrC family II proteins, the 
nucleotide and amino acid sequences were compared using an alignment tool. The amino acid 
sequences for each protein were aligned pairwise and percentage identity values were 
tabulated onto Table 3.1.1 for the amino acid sequences. 
The percentage amino acid identity values between each of all of the GtrC family II proteins 
tabulated on Table 3.1.1 and depicted on Figure 3.1.1 showed that GtrCBTP1 is particularly 
divergent from the rest of the GtrC Family II proteins. This is consistent with the findings of 
(Davies et al., 2013) which identified an earlier speciation event from a common ancestor than 
that which led to the formation of the rest of the gtrC family II genes. The gtr operon that gtrCBTP1 
is located on is found on the BTP1 prophage of S. Typhimurium D23580 while the rest of the gtrC 
family II genes are not thought to lie in any identified prophage. For the ease of future analysis, 
the amino acid sequences of all GtrC family II proteins except for GtrCBTP1 were aligned using 
Geneious Basic 5.6.7 and the resulting consensus sequence, referred to as ‘GtrC family II 
consensus’, will be used to represent all of these proteins.  
The oafA gene encodes for OafA, a protein that is functionally similar but with a different 
substrate specificity and hence, the amino acid sequence was expected to be significantly 
different than the GtrC family II proteins. From Table 3.1.1, the percentage similarity values 
between the amino acid sequences of OafA and the GtrC family II proteins are only between 
28.1% and 29.2%. Figure 3.1.1 shows that the amino acid sequence for OafA is least conserved 
among all of the amino acid sequences analysed. The acetyltransferase function of OafA and 
GtrC family II proteins could be carried out by any of the few conserved amino acid regions of 
the proteins while the cause for the substrate specificity might lie elsewhere in the amino acid 
sequences. 
Figure 3.1.2 highlights the various conserved regions between OafA and the GtrC family II 
proteins. The sequences that contribute to the functional similarities of OafA and GtrC family II 
might lie within the identified regions of conserved amino acids. To determine if these conserved 
amino acids are within any known domains, various domain prediction analyses were performed 
and discussed in the following sections. 
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Table 3.1.1. The percentage identity between amino acid sequences of GtrC family II and OafA proteins when aligned pairwise with the corresponding proteins. 
S. enterica strains with GtrC family II were identified black with specific names within brackets, while the serovar with OafA was identified by the red name followed 
by (OafA). SG = S. Gallinarum, SeD = S. Enteritidis, SSPA/SPA = S. Paratyphi A, STY = S. Typhi, STM = S. Typhimurium. For alignment parameters, see Section 2.3.2. 
Alignments were performed using Geneious Basic 5.6.7 (Drummond et al., 2012).
 
SEN 
P125109 
SG 
287/91 
SeD 
CT02021853 
SSPA 
12601 
SPA 
9150 
STY 
CT18 
STY 
TY2 
STM D23580 
(GtrCBTP1) 
SG 287/91 99.8% - - - - - - - 
SeD 
CT02021853 
99.5% 99.4% - - - - - - 
SSPA 12601 98.9% 98.8% 98.4% - - - - - 
SPA 9150 98.9% 98.8% 98.4% 100% - - - - 
STY CT18 98.6% 98.4% 98.1% 99.4% 99.4% - - - 
STY TY2 98.6% 98.4% 98.1% 99.4% 99.4% 100% - - 
STM D23580 
(GtrCBTP1) 
77.4% 77.2% 76.9% 77.5% 77.5% 77.2% 77.2% - 
STM (OafA) 29.2% 29.1% 28.1% 29.2% 29.2% 28.9% 28.9% 28.3% 
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Figure 3.1.1. Phylogenetic analysis of the amino acid sequences of GtrC family II proteins, 
including GtrCBTP1, and OafA from Salmonella. Depicted, is an unrooted tree with each branch 
being identified by the Salmonella strain followed by the name of the protein. Where applicable, 
each branch possesses a substitutions per site value and is drawn to a scale. OafA (denoted by 
STM - OafA) is the most divergent among the analysed proteins while GtrCBTP1 (denoted by STM 
D23580 - GtrC_BTP1) is the most divergent among the GtrC family II proteins. SG = S. Gallinarum, 
SeD = S. Enteritidis, SSPA/SPA = S. Paratyphi A, STY = S. Typhi, STM = S. Typhimurium. For 
alignment parameters, see Section 2.3.2. Alignments were performed and the tree was built 
using Geneious Basic 5.6.7 (Drummond et al., 2012). 
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Figure 3.1.2. Amino acid sequence alignments of OafA, GtrCBTP1 (GtrC_BTP1) and GtrC family II consensus. Conserved amino acid residues identified within all three 
sequences are highlighted in black and identified by the green identity bars, the residues aligned in only 2 out of the 3 sequences are highlighted in grey and identified  
by the brown identity bars and residues with no identity are not highlighted and do not have an identity bar. For alignment parameters, see Section 2.3.2. Alignments 
were performed using Geneious Basic 5.6.7 (Drummond et al., 2012).   
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3.2 Functional domain predictions of OafA, GtrCBTP1 and other GtrC family II proteins 
OafA and the GtrC family II proteins are thought to be functionally similar with their main 
functions being acetyltransferases involved in the addition of an acetyl group onto specific sugar 
residues on the LPS O-antigen. However, the differences lie in the sugar substrate specificity. 
Conserved amino acids identified in Section 3.1 between OafA and GtrC family II proteins might 
be conserved between proteins possessing certain functional domains. To determine if these 
proteins of interest might possess any known functional domains, the amino acid sequences 
were searched against the InterPro database and their identified functional domains were 
aligned below the respective amino acid regions. The results are depicted in Figures 3.2.1, 3.2.2 
and 3.2.3 for GtrC family II consensus, GtrCBTP1 and OafA respectively. 
OafA, GtrCBTP1 and other GtrC family II proteins (i.e. GtrC family II consensus) have the same 
functional domains and the same domain architectures with the acyltransferase 
(acetyltransferase) 3 domain (Pfam: PF01757) spanning most of the N-terminal half and SGNH 
hydrolase type esterase spanning the C-terminal half of the protein. 
3.2.1 Acyltransferase (acetyltransferase) 3 domain 
The acyltransferase 3 family of enzymes (Pfam: PF01757) consist of proteins that are involved in 
the transfer of acyl groups other than amino-acyl (i.e. from tRNAs). Proteins possessing this 
functional domain family are mostly uncharacterised and usually possess approximately 300 
amino acids. Hence, there is a need to expand our understanding of proteins within this domain 
family, structurally and functionally. Some of the proteins within this family are further classified 
into the membrane-bound O-acetyltransferase (MBOAT) group of enzymes. Acetyl is a form of 
acyl group, specifically possessing a methyl group bound to a carboxyl group. The N-terminal 
domain of OafA and all GtrC family II proteins will be referred to as the acyltransferase 3 domain 
while their function will continue to be referred to as acetyltransferases. 
3.2.2 SGNH hydrolase type esterase domain 
The SGNH hydrolase type esterase (SUPERFAMILY: SSF52266), or SGNH esterase for short, is a 
divergent family of esterases with underlying functions similar to the classical GDSL family of 
lipases and esterases. However, rather than having the usual α/β fold depicted on Figure 3.2.4(a) 
where alpha helices stack above about eight beta strands (Ollis et al., 1992), it possesses an 
α/β/α fold where about 8 alpha helices occupy both sides of 5 beta strands as shown on Figure 
3.2.4(b) using the rhamnogalacturonan acetylesterase (RGAE) of Aspergillus aculeatus 
(Mølgaard et al., 2000) for example. Both GDSL and SGNH esterases have the classical serine 
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Figure 3.2.1. Predicted functional domains of GtrC family II consensus. Predicted functional domains of within the protein were annotated as a coloured bar 
spanning the regions thought to represent the respective domains. Acyl_transf_3 refers to the group of proteins containing the acyltransferase 3 domain annotated 
on the PFAM database (PF01757). SGNH hydrolase refers to the group of proteins possessing the SGNH hydrolase type esterase domain annotated on the 
SUPERFAMILY database (SSF52266). Predictions were done using InterProScan (Jones et al., 2014, Hunter et al., 2011) on Geneious Basic 5.6.7 (Drummond et al., 
2012). 
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Figure 3.2.2. Predicted functional domains of GtrCBTP1. Predicted functional domains of within the protein were annotated as a coloured bar spanning the regions 
thought to represent the respective domains. Acyl_transf_3 refers to the group of proteins containing the acyltransferase 3 domain annotated on the PFAM database 
(PF01757). SGNH hydrolase refers to the group of proteins possessing the SGNH hydrolase type esterase domain annotated on the SUPERFAMILY database 
(SSF52266). Predictions were done using InterProScan (Jones et al., 2014, Hunter et al., 2011) on Geneious Basic 5.6.7 (Drummond et al., 2012). 
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Figure 3.2.3. Predicted functional domains of OafA. Predicted functional domains of within the protein were annotated as a coloured bar spanning the regions 
thought to represent the respective domains. Acyl_transf_3 refers to the group of proteins containing the acyltransferase 3 domain annotated on the PFAM database 
(PF01757). SGNH hydrolase refers to the group of proteins possessing the SGNH hydrolase type esterase domain annotated on the SUPERFAMILY database 
(SSF52266). Predictions were done using InterProScan (Jones et al., 2014, Hunter et al., 2011) on Geneious Basic 5.6.7 (Drummond et al., 2012). 
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Figure 3.2.4. Topological diagram of (a) general classical GDSL esterase following an α/β fold, and (b) SGNH hydrolase type esterase following an α/β/α fold which 
is based on rhamnogalacturonan acetylesterase (RGAE) from Aspergillus aculeatus (Mølgaard et al., 2000). The α-helices are depicted as cylinders, β-strands are 
depicted as arrows and loops between α-helices and β-strands are represented by single solid black lines. Typical serine esterase catalytic residues of GDSL esterase 
and the known serine esterase catalytic residues of RGAE were identified by the red crosses with their respective names. 
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esterase Ser-Asp-His catalytic triad but they are located in different positions on their secondary 
structures. Notably, the catalytic aspartate and histidine residues in RGAE are separated by two 
amino acid residues rather than the more significant distance between the two catalytic residues 
in the GDSL esterase as shown on Figure 3.2.4. Mølgaard et al. (2000) also identified two amino 
acid residues in RGAE, Gly42 and Asn74, which form the oxyanion hole which functions as a 
stabiliser for the active site during binding of the substrate. 
3.2.3 Domain architecture of OafA and GtrC family II proteins  
The functional domain detection of OafA and GtrCBTP1 using the InterProScan identified two 
potential functional domains, acyltransferase 3 (Pfam: PF01757) and SGNH hydrolase type 
esterase (SUPERFAMILY: SSF52266), on both proteins with the former being on the N-terminal 
end and the latter on the C-terminal end of the proteins. From here henceforth, the N-terminal 
Acyltransferase 3 and C-terminal SGNH hydrolase type esterase domain architecture will be 
referred to as the acyltr3-SGNH domain architecture. Proteins of similar domain architectures 
were determined by searching for either PF01757 or SSF52266 on the InterPro database. As of 
February 2015, the search returned with 13627 proteins predicted or known to have the Acyltr3-
SGNH domain architecture.  
One notable protein that was identified by this search is the S. aureus peptidoglycan O-
acetyltransferase, OatA. S. aureus is known to be a pathogen that is fully unaffected by lysozyme, 
due to the presence of this protein. The modification caused by OatA gives S. aureus the ability 
to persist and colonise in the host (Bera et al., 2005).  
3.2.4 Multiple component acetyltransferase systems using the acyltransferase 3 and SGNH 
hydrolase type esterase domains on separate proteins  
Rather than having both the acyltransferase 3 and SGNH hydrolase type esterase domains on 
the same protein and hence, having the Acyltr3-SGNH domain architecture, some O-acetylation 
mechanisms utilise two separate proteins with each domain being on a separate subunit.  
3.2.4.1 PatA and PatB of Neisseria gonorrhoeae (N. gonorrhoeae) 
Like OatA in the gram-positive S. aureus, PatA and PatB are involved in the O-acetylation of the 
C6 hydroxyl group of muramic acid residues within the peptidoglycan of the Gram-negative N. 
gonorrhoeae and N. meningitidis. PatA is thought to be the MBOAT that transfers an acetyl to 
the periplasm where PatB then transfers the acetyl onto the peptidoglycan (Moynihan and 
Clarke, 2010). PatB was predicted to be an SGNH hydrolase type esterase enzyme, possessing 
the α/β/α fold and the Ser-Asp-His catalytic triad (Moynihan and Clarke, 2010) which are 
arranged in a similar way as that of RGAE as shown on Figure 3.4.2.  
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3.2.4.2 AlgF, AlgI, AlgJ and AlgX of Pseudomonas aeruginosa (P. aeruginosa) 
In P. aeruginosa, alginate, a biofilm exopolysaccharide, is made up of a linear chain of D-
mannuronic acid which can be acetylated at the C2 and C3 hydroxyl groups. The alginate is 
modified in the periplasm through O-acetylation by four proteins; AlgF, AlgI, AlgJ and AlgX. Like 
PatB and PatA in N. gonorrhoeae and meningitidis, AlgJ and AlgX are both predicted to be SGNH 
hydrolase type esterases with both predicted to have the α/β/α fold and the SGNH esterase type 
catalytic triad and AlgI is predicted to be an MBOAT enzyme respectively (Riley et al., 2013), 
(Baker et al., 2014). Replacement of each of the three catalytic residues with alanine in AlgX 
resulted in the complete absence of enzyme activity while replacement mutations performed in 
AlgJ only reduced enzymatic activities by 80%.  
3.3 Transmembrane Structure Prediction of OafA and GtrCBTP1 
The functional domain prediction classified the N-terminal region of OafA and GtrCBTP1 as 
acyltransferase 3. This domain family consist of proteins that are within the inner membrane 
including those within the MBOAT family of enzymes and to determine if the same is true with 
OafA and the GtrC family II proteins, the sequences were uploaded onto the TMHMM v2.0 
server which predicts the presence of transmembrane helices and the location of other regions 
which are not involved in a transmembrane helix using the hydrophobic and hydrophilic 
characteristics of the amino acids while also giving the value of likelihood that the region is 
actually as predicted by the software.   
3.3.1 Transmembrane helices predicted in the N-terminal region of OafA and GtrCBTP1 
Figures 3.3.1 and 3.3.2 represents the transmembrane helix predictions for OafA and GtrCBTP1 
respectively. The N-terminal region of the proteins, which are putatively classified in the 
acyltransferase 3 family of functional domains, are predicted to possess around 9 to 11 
transmembrane helices. This is consistent with the hypothesis that the N-terminal region of both 
proteins are highly related to or within the MBOAT family of enzymes. 
3.3.2 Periplasmic region predicted in the C-terminal region of OafA and GtrCBTP1 
Kintz et al. (2015) utilised a PhoA fusion on amino acid number 370, which is the start of the 
predicted C-terminal periplasmic tail, and at amino acid number 640, which is at the C-terminal 
end of the protein. PhoA is an alkaline phosphatase which can only fold when in the periplasm. 
Its activity can be assayed using XPhos (5-Bromo-4-chloro-3-indolyl-phosphate) supplemented  
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Figure 3.3.1. Transmembrane prediction of OafA. Amino acid sequence of OafA was put into the TMHMM v2.0 server (Sonnhammer et al., 1998, Krogh et al., 2001). 
Red blocks refer to regions of amino acids that are within a transmembrane helix, the blue line represents the region of amino acids that are within the inside of the 
membrane which refers to the cytoplasm of the bacteria and the purple line represents the region of amino acids that are outside the membrane which refers to 
the periplasm of the bacteria.  
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Figure 3.3.2. Transmembrane prediction of GtrCBTP1. Amino acid sequence of GtrCBTP1 was put into the TMHMM v2.0 server (Sonnhammer et al., 1998, Krogh et al., 
2001). 11 transmembrane helices, represented by the red blocks, were identified. The blue line represents the region of amino acids that are within the inside of 
the membrane which refers to the cytoplasm of the bacteria and the purple line represents the region of amino acids that are outside the membrane which refers 
to the periplasm of the bacteria.  
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LB agar plates. If the region of the protein PhoA has been fused into is in the periplasm, the 
colony grown on the XPhos supplemented LB agar plates will turn blue due to the successful 
cleavage of XPhos by PhoA and hence, deemed as PhoA positive. Both fusions were PhoA 
positive which suggests that they are within the periplasmic space. 
The predicted SGNH-hydrolase type esterase domains are hence, to be within the periplasmic 
space. This could mean that this SGNH hydrolase domain might have a downstream function in 
the acetylation process of the LPS O-antigen sugar residues, after the predicted MBOAT like N-
terminal acyltransferase 3 region. This characteristic is parallel to that of the single or multiple 
protein O-acetyltransferase systems of OatA in S. aureus, PatA/PatB in N. gonorrhoeae and 
AlgI/AlgJ and AlgX in P. aeruginosa mentioned in Section 3.2.3 and 3.2.4. To determine if the C-
terminal regions might adopt a typical SGNH hydrolase type esterase α/β/α fold, a structural 
prediction of the proteins needed to be performed. 
3.4 C-terminal tail structure predictions of OafA and GtrCBTP1 
The amino acid sequences of OafA and GtrCBTP1 were uploaded onto the SWISS-MODEL server 
(http://swissmodel.expasy.org/) (Arnold et al., 2006, Guex et al., 2009, Kiefer et al., 2009, 
Schwede et al., 2003) where models for both proteins are built using known protein structures 
from the Protein Data Bank (PDB) as the templates. The results were then visualised using the 
Swiss-PdbViewer 4.1.0 (Guex and Peitsch, 1997) and depicted in Figure 3.4.1. As an example of 
a known and characterised protein of the SGNH hydrolase type esterase family, the known 
crystal structure of rhamnogalacturonan acetylesterase (RGAE) of Aspergillus aculeatus (PDB: 
1DEO) was used as a comparative structure and is illustrated on Figure 3.4.2. The predicted 
structure of the periplasmic C-terminal region of OafA, shown on Figure 3.4.1(a), was modelled 
against a GDSL-like lipase from Parabacteroides distasonis (PDB: 3P94) while that of GtrCBTP1, 
shown on Figure 3.4.1(b) was predicted using a carbohydrate esterase from Clostridium 
thermocellum (PDB: 2VPT) as a template. 
The predicted periplasmic C-terminal tail region of both OafA and GtrCBTP1 possesses the typical 
SGNH hydrolase α/β/α fold with the predicted catalytic residues being on the top of the α/β/α 
fold as shown on Figure 3.4.1. The known structure and catalytic sites of RGAE, depicted on 
Figure 3.4.2, is similar to that of the predicted structures of OafA and GtrCBTP1 and the catalytic 
sites are found in similar positions. 
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Figure 3.4.1. Predicted crystal structures of the C-terminal periplasmic tails of (a) OafA and (b) GtrCBTP1. OafA was predicted using a GDSL-like lipase from 
Parabacteroides distasonis (PDB: 3P94) and  GtrCBTP1 using a carbohydrate esterase from Clostridium thermocellum (PDB: 2VPT). α-helices are coloured in dark green, 
β-strands are coloured blue and coils are coloured orange. Amino acids of predicted catalytic triads are identified by crosses; black crosses are for amino acids that 
are found on coils and the white crosses are for amino acids that are found on the α-helices. Amino acid names and positions are also included with their respective 
crosses. 
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Figure 3.4.2. Crystal structure of rhamnogalacturonan acetylesterase (RGAE) of Aspergillus aculeatus (PDB: 1DEO). α-helices are coloured in dark green, β-strands 
are coloured blue and coils are coloured orange. Amino acids of the known catalytic triad are identified by black crosses. Amino acid names and positions are also 
included with their respective crosses.  
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Mølgaard et al. (2000) co-crystallised RGAE with the sulphate ion and deduced the position and 
identity of the residues making up the catalytic triad of the protein by identifying the presence 
of hydrogen bonding with the sulphate ion.  PatB, the peptidoglycan O-acetyltransferase of N. 
gonorrhoea, possesses the same catalytic triad which when substituted individually with alanine, 
resulted in either in the complete inactivation of the enzyme or a significant decrease in protein 
activity (Moynihan and Clarke, 2014). Since the catalytic triad is also found on OafA and GtrCBTP1, 
mutating these potential catalytic residues should abrogate or suppress the function of both 
proteins. 
RGAE is an acetylesterase which functions as a deacetylase of the polysaccharide 
rhamnogalacturonan, as opposed to being an acetyltransferase which OafA and GtrCBTP1 are 
thought to be. The difference in function between the LPS acetyltransferases and RGAE suggest 
that the catalytic triad is an intermediate necessary for both acetyltransferase and 
acetylesterase functions with the site for the specific functions being elsewhere in the protein 
or the proteins act as both a transferase and esterase for the regulation of the amount of 
acetylation on the various. PatB was also found to have a higher specificity for the non-O-
acetylated peptidoglycan molecules (Moynihan and Clarke, 2010). If the C-terminal domains of 
OafA and GtrCBTP1 are similar to PatB, there should be a binding site for the non-O-acetylated 
LPS molecule within the domain itself. Due to the highly specific nature of the O-antigen 
molecule of the LPS, no known O-antigen binding motifs were identified in silico. To determine 
where the binding site is, OafA and GtrCBTP1 can be co-crystallised with pure LPS O-antigen 
molecules. 
3.5 Chapter 3 Conclusion 
With the findings discussed in this chapter, OafA and GtrCBTP1 are predicted to be two domain 
proteins with the N-terminal domain being of the acyltransferase 3 domain and the periplasmic 
C-terminal tail being the SGNH hydrolase type esterase domain. Further analyses of the C-
terminal periplasmic tail identified common SGNH hydrolase characteristics in the proteins of 
interest, such as the position of the catalytic triad of Ser-Asp-HIs and their predicted 3D 
structures.  
To further support these hypotheses, extensive experimental protein analyses should be 
performed including, but not restricted to, structural studies, in vitro and in vivo functional 
analyses.              
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Chapter 4 Introduction 
Bioinformatics analysis and further support from findings by Kintz et al. (Kintz et al., 2015) for 
GtrCBTP1 determined that OafA and GtrCBTP1 are likely to be highly similar with both proteins 
predicted to possess a membrane bound N-terminal domain and a SGNH hydrolase type 
esterase C-terminal periplasmic domain. Preliminary in silico comparisons with known SGNH 
hydrolase type esterase proteins suggests that these proteins possess the characteristics of this 
family of proteins in their respective periplasmic C-terminal domain. 
To determine if the SGNH hydrolase C-terminal domain of both proteins can fold independently 
of their respective N-terminal inner-membrane bound domains, the C-terminal SGNH hydrolase 
type esterase region of the proteins were attempted to be expressed, purified and characterised 
alongside the full length proteins. 
An excellent method for the characterisation of proteins is the determination of their various 
structures. This should provide confirmation on the different forms the protein can adopt and 
the sites of the ligand interactions. Structural determination of OafA and GtrCBTP1 is therefore 
one of the main objectives of this project. Structural determination methods like NMR and X-ray 
crystallography require pure samples of proteins. Alongside the biophysical structural 
determination experiments, biochemical experiments could also be performed to characterise 
these proteins in vitro to determine which substrates are able to interact with these proteins 
and whether or not the proteins are monomeric, among others. To obtain this, these proteins 
were expressed in an expression strain and purified using various methods which are discussed 
in the following sections. 
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4.1 Expression of OafA and GtrCBTP1 from the pBADcLIC Vector 
Expression of both OafA and GtrCBTP1 were performed by inserting the isolated genes into the 
pBADcLIC vector possessing the arabinose-inducible araBAD promoter, PBAD, upstream of the 
inserted oafA and gtrC BTP genes. Hence, expression of these proteins can be controlled using 
different concentrations of the inducer, L-arabinose.  
The sequence encoding for the full length and the C-terminal putative SGNH hydrolase domains 
OafA and GtrCBTP1 were isolated via PCR from the genome of S. Typhimurium LT2 and S. 
Typhimurium D23580 respectively. All four sequences were inserted into the vector separately 
via ligation independent cloning (LIC) and then transformed into a standard E. coli cloning strain. 
The inserts were confirmed by sequencing (Section 2.4.7.3).  
From here henceforth, the pBADcLIC vector containing the full length oafA gene will be called 
pOafA and the vector encoding the full length GtrCBTP1 protein will be called pGtrCBTP1. The vector 
containing the sequence encoding the C-terminal tail region of OafA will be called pOafA(C-tail) 
and GtrC BTP1 will be called pGtrCBTP1(C-tail).  When expressed from the vector, the proteins will 
possess a C-terminal deca-His tag which will allow the expressed proteins to be detected by anti-
poly His antibodies and isolated from the expression strain by immobilised metal affinity 
chromatography (IMAC). 
Trial protein expression were performed using E. coli DH5α for pOafA, pOafA(C-tail) and 
pGtrCBTP1(C-tail) while pGtrCBTP1 was expressed from E. coli XL-1 Blue. A final concentration of 
1mM L-arabinose was used with induction taking place for four hours after the cells reached an 
OD600 of 0.5 at 30°C. With the deca-His tag introduced, the full length OafA is 72.4 kDa, full length 
GtrCBTP1 is 74.1 kDa, the C-terminal domain of OafA is 32.9 kDa and the C-terminal domain of 
GtrCBTP1 is 32.3 kDa. 
4.1.1 Trial expression of the full length proteins of OafA and GtrCBTP1 
Owing to the predicted presence of the transmembrane helices, the full length proteins OafA 
and GtrCBTP1 are expected to be in the insoluble fractions of the cell lysates. The western blot 
analysis from Figure 4.1.1(a) and 4.1.2(a) suggests that, with the trial expression conditions 
mentioned above, the full length OafA and GtrCBTP1 might have been successfully expressed as 
the anti-His antibody binding was detected via secondary antibody binding and 
chemiluminescent visualisation. In addition, the signal potentially representing these proteins 
were detected in the insoluble fraction of the cell lysates. A less intense signal was observed in 
the total protein fraction of only OafA and not GtrCBTP1. This could be because more OafA was 
produced than GtrCBTP1. The protein samples, however, were not in the same position after 
protein separation as the corresponding protein molecular weight marker bands of 
approximately 72 kDa and 74 kDa for OafA and GtrCBTP1 respectively.
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Figure 4.1.1. Expression Trials of the Full Length OafA and GtrCBTP1. (a) Western analysis with the anti- tetra His antibody, and (b) coomassie stained 12% SDS-PAGE 
gels. Lane 1 = Total proteins from lysis of the uninduced DH5α with pOafA, Lanes 2 = Total proteins from the lysis of the induced cultures of DH5α with pOafA, Lane 
3 = soluble fraction from the lysis of the induced cultures of DH5α with pOafA, Lane 4 = insoluble fractions isolated from the lysis of the induced cultures of DH5α 
with pOafA, Lane 5 = Total proteins from lysis of the non-induced XL-1 Blue with pGtrCBTP1, Lanes 6 = Total proteins from the lysis of the induced cultures of XL-1 
Blue with pGtrCBTP1, Lane 7 = soluble fraction from the lysis of the induced cultures of XL-1 Blue with pGtrCBTP1 and Lane 8 = insoluble fractions isolated from the lysis 
of the induced cultures of XL-1 Blue with pGtrCBTP1. 
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Figure 4.1.2. Expression Trials of the C-terminal Tail of OafA and GtrCBTP1. (a) Western analysis with the anti- tetra His antibody, and (b) coomassie stained 12% 
SDS-PAGE gels. Lane I = Total proteins from lysis of the uninduced DH5α with pOafA(C-tail), Lanes II = Total proteins from the lysis of the induced cultures of DH5α 
with pOafA(C-tail) respectively, Lane III = soluble fraction from the lysis of the induced cultures of DH5α with pOafA(C-tail) respectively, Lane IV = insoluble fractions 
isolated from the lysis of the induced cultures of DH5α with pOafA(C-tail), Lane V = Total proteins from lysis of the non-induced DH5α with pGtrCBTP1(C-tail), Lanes 
VI = Total proteins from the lysis of the induced cultures of DH5α with pGtrCBTP1(C-tail), Lane VII = soluble fraction from the lysis of the induced cultures of DH5α 
with pGtrCBTP1(C-tail) and Lane VIII = insoluble fractions isolated from the lysis of the induced cultures of DH5α with pGtrCBTP1(C-tail). 
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This could be attributed to the interactions of these proteins with sodium dodecyl sulphate 
(SDS), an anionic detergent, in the PAGE gel used for separation of the proteins. Depending on 
the amount of SDS, the nature and number of hairpins formed by the transmembrane helices 
and the state of folding of the proteins (i.e. whether the proteins are fully denatured or not) 
(Rath et al., 2009). With the current SDS-PAGE protocol adopted, both OafA and GtrCBTP1 run at 
just under the level where 58 kDa band of the protein molecular weight marker lies. The primary 
antibody used is a poly-histidine specific anti-tetra His antibody which suggests that any signals 
observed on the western analyses will be a protein possessing at least 4 consecutive histidines, 
which should include the expressed proteins of interest.  Both the total proteins of the 
uninduced and soluble fraction of the induced E. coli clones cell lysates expressing either OafA 
or GtrCBTP1 did not produce any signals after staining with the primary antibody. This provides 
further support that any signals observed on the western analysis would most likely be the 
proteins of interest. The smear above the ~58 kDa signal with respect to the protein marker seen 
in the western analysis of the insoluble fraction sample of the cell lysate of the strain expressing 
OafA could be caused by the aggregation of the expressed OafA protein. Prior to the SDS-PAGE 
protein separation, the insoluble fractions were not boiled due to the likelihood that the 
proteins will aggregate in the presence of heat and SDS (Andrew Bretnall, personal 
communication). Instead, they were heated at 65°C for approximately 10 minutes. Hence, future 
preparation of insoluble fractions prior to SDS-PAGE gel separation were performed at 55°C for 
approximately 20 minutes in an attempt to ensure that the proteins aggregate less.  
A separate signal was observed at approximately 30 kDa in the insoluble fraction sample of the 
cell lysate of both expression strains with a stronger signal observed for the strain expressing 
OafA. Two reasons were hypothesised to have caused the presence of this extra signal. Firstly, 
GtrCBTP1 was confirmed to have a transmembrane region and a periplasmic tail region (Kintz et 
al., 2015) with the same predicted for OafA. When expressed, these proteins could have had 
some form of cleavage that resulted in the separation of these two regions, producing two ~30 
kDa fragments. If this were to have happened, the deca-His tag would be in the periplasmic 
soluble ~30 kDa fragment. Since the signal at 30 kDa was only found in the insoluble fractions of 
the cell lysates, this would be an unlikely cause unless the periplasmic soluble fragment were to 
aggregate and form an inclusion body. A second and more likely reason why this 30 kDa signal 
is present could be due to a contaminating native transmembrane protein found in the E. coli 
expression strains. One such contaminating protein would be a zinc transporter protein, ZitB, 
which possess a molecular weight of 34.6 kDa. The presence of a native tetra histidine c-terminal 
end of ZitB could be a problem in western analysis using the anti-tetra His primary antibody if 
the expressed proteins were to be in the 30 kDa region and it could also be a major problem 
during protein purification. 
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To confirm if the proteins are indeed OafA and GtrCBTP1, protein identification by peptide mass 
fingerprinting would have to be done after a large scale expression of these proteins, as a larger 
amount of proteins would be required for the successful detection of the peptide masses after 
protein digestion. Prior to protein identification, all future western blot analysis of the full length 
OafA and GtrCBTP1 proteins will based on the assumption that the proteins are running at just 
under 58 kDa.  
4.1.2 Trial expression of the C-terminal tails of OafA and GtrCBTP1 
Due to the absence of the putative transmembrane helices, these proteins are expected to be 
in the soluble fraction of the various cell lysates. The putative periplasmic C-terminal SGNH 
hydrolase domain of OafA and GtrCBTP1 were not successfully expressed with only a very faint 
signal observed at the 30  kDa protein marker level for the insoluble fraction of the cell lysate of 
the strain expressing the C-terminal tail of GtrCBTP1. However, the signal could also be a 
contaminating protein like ZitB. Due to the need for an expression protocol that would work for 
their expression and the potential confusion with contaminating proteins, the C-terminal tail 
proteins will not be purified and the following experiments will only be on the full length proteins 
of OafA and GtrCBTP1. 
4.2 Expression optimisation of OafA and GtrCBTP1 
4.2.1 Parameters for optimisation 
Protein structure determination methods such as X-ray crystallography require pure proteins in 
the milligram (mg) scale. Photosynthetic proteins were some of the first crystallised membrane 
proteins due to their abundance in nature, unlike most other membrane proteins (Grisshammer 
and Tateu, 1995, Ostermeier and Michel, 1997). Under the same expression conditions, more 
soluble proteins are expressed multiple folds higher than insoluble proteins from an expression 
vector in an expression host. Naturally, a larger culture volume of the E. coli strains expressing 
the proteins would be prepared prior to protein isolation as compared to that of the host strains 
expressing soluble proteins. However, there is also a need to optimise the expression of these 
proteins in order to get as much proteins as possible from a certain volume of culture. Multiple 
parameters could be varied in order to find the optimal expression strategy.  
4.2.1.1 E. coli expression strains 
Firstly, a different expression strain could perform better in expressing the proteins of interest. 
The inducer used is L-arabinose, a sugar that is able to be metabolised by E. coli DH5α and XL-1 
Blue strains. E. coli MC1061 is an E. coli K-12 based strain that notably possesses an inactive 
arabinose operon with the Δ(ara-leu)7697 deletion mutation, which means that the araB, araA 
and araC were removed, and araD possesses a mutation at amino acid 139 (Casadaban and 
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Cohen, 1980). With these mutations, the E. coli MC1061 strain is unable to metabolise L-
arabinose, thus allowing for a constant amount of L-arabinose present for induction.  
4.2.1.2 Induction temperature 
The next parameter of protein expression that could be modified is the temperature at which 
the induction of the protein expression happens. Cells exposed to mild hypothermia have slower 
cell processes, which allows the coupling of transcription of the protein of interest with the 
translation and then, translation with post-translational processes (Chou, 2007). If these 
processes are not coupled, cell viability may be compromised. If transcription outruns 
translation, accumulation of mRNA would occur which may cause the destruction of ribosomes 
(Dong et al., 1995). In addition, the lower temperature would suppress the activity of most 
bacterial proteases, allowing for the reduced degradation of the potentially vulnerable protein 
of interest and hence, increasing the amount of protein for purification (Hunke and Betton, 
2003, Pinsach et al., 2008). The expression optimisation of OafA and GtrCBTP1 included two sets 
of cultures grown to 37°C and underwent separate temperature shifts to 20°C and 30°C for 
induction.  
4.2.1.3 Concentration of inducer 
As mentioned, the coupling of transcription and translation is vital for the viability of the cell and 
hence, optimal protein production. Another factor that can affect the coupling of these 
processes is the concentration of the inducer, L-arabinose, added into the culture. The pBADcLIC 
vector used to harbour oafA and gtrCBTP1 possesses the araBAD promoter system from the 
arabinose operon which is titratable (Guzman et al., 1995). A low concentration would result in 
the insufficient production of the protein of interest while an excessive amount of the inducer 
might uncouple transcription and translation. Hence, an optimal concentration of inducer would 
be beneficial in the optimisation of expression of OafA and GtrCBTP1. Three concentrations of L-
arabinose at 0.001%, 0.01% and 1% (w/v) were tested in the following expression optimisation 
experiments.  
4.2.1.4 Duration of incubation 
A decreased induction temperature and a small concentration of inducer would result in a 
slower rate of protein production. Hence, a longer duration of induction might be necessary for 
the optimal expression of these protein. In the following optimisation experiments, one set of 
cultures was induced for 4 hours and another set of cultures was induced overnight 
(approximately 19 hours). 
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4.2.2 Protein expression optimisation   
OafA and GtrCBTP1 were expressed in either the initial cloning strains mentioned in Section 4.1, 
E. coli DH5α and XL-1 Blue, or E. coli MC1061 using the inducer concentrations of either 0.001%, 
0.01% or 1% (w/v) L-arabinose at either 30°C or 37°C for 4 hours or overnight (approximately 19 
hours). Every permutation of the above mentioned conditions were tested and the protein 
expressions were assessed via western analysis shown on Figures 4.2.1 to 4.2.4 along with their 
respective coomassie stained gels.  
4.2.2.1 Expression optimisation of OafA 
The optimisation of the expression of OafA was performed and the protein expression levels 
were analysed via western analysis shown on Figures 4.2.1 and 4.2.2 with the former 
representing all samples from E. coli DH5α based protein expressions and the latter representing 
all samples from E. coli MC1061 based protein expressions. The western analyses shown on 
Figure 4.2.1 suggests that 0.0001% (w/v) L-arabinose is insufficient for the expression of OafA 
while 1% and 0.01% (w/v) L-arabinose resulted in the production of comparatively similar 
amounts of proteins from E. coli DH5α induced at the same temperature. The signal from the 
western analyses of proteins from the E. coli DH5α induced at 30°C seemed to be fractionally 
more intense than that of the strains induced at 20°C. This difference could be attributed to 
more proteins being loaded into the SDS-PAGE gel for the insoluble fraction protein separation 
of the former. The coomassie stained gels of the insoluble fraction protein separation of the E. 
coli DH5α induced at 30°C shown on Figure 4.2.1(b) had more intense staining for the protein 
samples from the cultures induced with 0.01% and 1% (w/v) L-arabinose as compared to the 
corresponding protein samples on Figure 4.2.1(d) for the E. coli DH5α induced at 20°C. From 
Figure 4.2.1, the cultures induced for 4 hours with either 1% or 0.01% (w/v) L-arabinose at both 
20°C and 30°C seem to have produced a higher signal on the western analyses, suggesting that 
these cultures are capable of producing the largest amount of proteins within the E. coli DH5α 
based expression cultures. 
Figure 4.2.2(c) represents the western analyses performed for the comparison of the relative 
expression levels of OafA from the cultures of E. coli MC1061. Unlike the expression of OafA 
from E. coli DH5α, the inability to metabolise arabinose allows protein expression from E. coli 
MC1061 to occur even when induced with 0.0001% (w/v) L-arabinose. Expression of OafA across 
all cultures of E. coli MC1061 induced at the same temperatures seem to be relatively similar as 
the signal intensities do not very significantly. For E. coli MC1061 induced at 20°C, the signal 
intensity for the protein samples of the cultures induced overnight is less than that of the 4 hour 
induced samples. Like that of the E. coli DH5α cultures, this could be attributed to the fact that 
less  
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Figure 4.2.1. Western analyses of the expression of OafA from E. coli DH5α. Proteins expressed 
at (a) 20°C and (c) 30°C with their respective coomassie stained gels (b) and (d). 1%, 0.01% and 
0.0001% represents the concentration in w/v of the inducer, L-arabinose. NI = no inducer added, 
4h = cultures were induced for 4 hours, ON = cultures were induced overnight. Samples were 
the insoluble fractions of the various cell lysates. SDS-PAGE was performed with a 12% SDS-
PAGE gel, under denaturing and reducing conditions.  
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Figure 4.2.2. Western analyses of the expression of OafA from E. coli MC1061. Proteins 
expressed at (a) 20°C and (c) 30°C with their respective coomassie stained gels (b) and (d). 1%, 
0.01% and 0.0001% represents the concentration in w/v of the inducer, L-arabinose. NI = no 
inducer added, 4h = cultures were induced for 4 hours, ON = cultures were induced overnight. 
Samples were the insoluble fractions of the various cell lysates. SDS-PAGE was performed with 
a 12% SDS-PAGE gel, under denaturing and reducing conditions.  
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proteins from the overnight induced cultures were added into the SDS-PAGE gel for protein 
separation as shown in the photo of the coomassie stained gel on Figure 4.2.2(b). The same lack 
of intensity of the coomassie stained protein sample from the overnight induced culture as 
compared to the 4 hour induced culture of E. coli MC1061 induced at 30°C is observed on Figure 
4.2.2(d). However, the western analyses shown on Figure 4.2.2(c) suggests that there was no 
reduction in signal intensities between the overnight and 4 hour induced cultures despite the 
stark differences in coomassie staining. Hence, the overnight cultures of E. coli MC1061 induced 
with either the 0.0001%, 0.01% or 1% (w/v) L-arabinose at 30°C seemed to have produced the 
largest amount of OafA among the E. coli MC1061 based expression cultures. 
Comparing the western analyses and the respective coomassie stained gels containing proteins 
samples from the E. coli DH5α cultures induced for 4 hours with either 1% or 0.01% (w/v) L-
arabinose at both 20°C and 30°C and the overnight cultures of E. coli MC1061 induced with 
either the 0.0001%, 0.01% or 1% (w/v) L-arabinose at 30°C, the latter was decided to be the 
optimum conditions with the various conditions tested. Using the results of the optimisation 
experiments, future expression of OafA was decided to be performed using the E. coli MC1061 
expression host, with 0.01% (w/v) L-arabinose at 30°C overnight.  
4.2.2.2 Expression optimisation of GtrCBTP1 
Expression optimisation of GtrCBTP1 was performed using the conditions mentioned in Section 
4.2.1 and the levels of protein expression were analysed using western analyses which are 
depicted with the respective coomassie stained gels on Figure 4.2.3.  
The results of the expression optimisation of GtrCBTP1 are similar to that of the expression 
optimisation of OafA. For protein expression cultures of E. coli XL-1 Blue strains, no or negligible 
expression of GtrCBTP1 was observed on the western analyses of cultures induced with 0.0001% 
(w/v) L-arabinose. Like E. coli DH5α, E. coli XL-1 Blue strains are able to metabolise arabinose 
and therefore, the 0.0001% (w/v) L-arabinose added to the cultures for induction was taken up 
by the host and metabolised before it was able to induce significant expression of GtrCBTP1.  
E. coli XL-1 Blue induced with 0.01% (w/v) L-arabinose overnight at both induction temperatures 
were observed to have produced much less GtrCBTP1 than the 4 hour induced culture. The 
coomassie stained gels for both induction temperatures shown on Figure 4.2.3(b) and (d) 
depicted a stronger stained band for the lanes representing the proteins from these samples 
and also that of the cultures of E. coli XL-1 Blue induced with 0.0001% (w/v) L-arabinose as 
compared to that of the cultures induced with 1% (w/v) L-arabinose. Due to its intensity, these 
bands might represent heat-shock proteins (Andrew Bretnall, personal communication). The 
peculiar presence of these bands on the select lanes on the coomassie stained gels, suggests 
that the proteins making up  
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Figure 4.2.3. Western analyses of the expression of GtrCBTP1 from E. coli XL1-Blue. Proteins 
expressed at (a) 20°C and (c) 30°C with their respective coomassie stained gels (b) and (d). 1%, 
0.01% and 0.0001% represents the concentration in w/v of the inducer, L-arabinose. NI = no 
inducer added, 4h = cultures were induced for 4 hours, ON = cultures were induced overnight. 
Samples were the insoluble fractions of the various cell lysates. Samples were the insoluble 
fractions of the various cell lysates. SDS-PAGE was performed with a 12% SDS-PAGE gel, under 
denaturing and reducing conditions.  
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Figure 4.2.4. Western analyses of the expression of GtrCBTP1 from E. coli MC1061. Proteins 
expressed at (a) 20°C and (c) 30°C with their respective coomassie stained gels (b) and (d). 1%, 
0.01% and 0.0001% represents the concentration in w/v of the inducer, L-arabinose. NI = no 
inducer added, 4h = cultures were induced for 4 hours, ON = cultures were induced overnight. 
Samples were the insoluble fractions of the various cell lysates. Samples were the insoluble 
fractions of the various cell lysates. SDS-PAGE was performed with a 12% SDS-PAGE gel, under 
denaturing and reducing conditions.  
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the intensity of these bands are only present overnight and in the absence of a concentration of 
arabinose around or higher than 1% (w/v). The cultures of E. coli XL-1 Blue induced with 1% (w/v) 
L-arabinose at both tested temperatures were observed to have produced the highest yield of 
GtrCBTP1 as shown by the western analyses of the protein expression of these cultures on Figure 
4.2.3 (a) and (c). An extra single signal is observed on each of the lanes containing the following; 
E. coli XL-1 Blue induced with 1% (w/v) L-arabinose at 20°C overnight, E. coli XL-1 Blue induced 
with 1% (w/v) L-arabinose at 30°C for 4 hours and overnight. These single signals at less than 25 
kDa with respect to the marker suggests that some form of degradation might have happened 
to the full length GtrCBTP1 proteins. Nonetheless, among the cultures of E. coli XL-1 Blue used for 
the expression of GtrCBTP1, the cultures induced with 1% (w/v) L-arabinose at either 20°C or 30°C 
for either 4 hours or overnight seemed to have produced the strongest signals on the western 
analyses which most likely translates to the highest output of GtrCBTP1 with the various 
parameters tested. 
Expression of GtrCBTP1 performed using the host E. coli MC1061 was successful across all 
concentrations of L-arabinose as shown on Figure 4.2.4. The signal intensities on the western 
analyses that are thought to represent GtrCBTP1 were consistently intense throughout the 
conditions tested with the exception of the cultures induced with 0.0001% (w/v) L-arabinose for 
4 hours and overnight. The cultures induced for 4 hours had a weaker signal as compared to that 
of the overnight induced cultures. This is most likely due to the fact that less amount time is 
allowed for induction to occur and hence, less proteins were produced.  
The protein samples loaded onto the SDS-PAGE gel for protein separation of the samples from 
the overnight induced cultures were less than that of the 4 hour induced cultures and the no 
induction negative control as seen in the lighter coomassie stained bands on the lanes 
representing these samples shown on Figure 4.2.4(b) and (d). However, the intensities of the 
signals on the western analyses were similar for the overnight induced cultures rather than the 
4 hour cultures which suggests that the overnight induced cultures were expressing more 
GtrCBTP1 than the 4 hour induced cultures. The cultures induced at 30°C also had more intense 
signals than that of the 20°C with the culture induced with 0.01% (w/v) L-arabinose overnight 
being the most intense. Hence, the E. coli MC1061 strain expressing GtrCBTP1 induced with 0.01% 
(w/v) L-arabinose overnight would be chosen for future expression of GtrCBTP1. 
4.3 Large Scale Production and Purification of OafA and GtrCBTP1 
Using the chosen expression conditions from Section 4.2.2, OafA and GtrCBTP1 were expressed 
from a much larger culture volume of 2.5 L each in an attempt to purify the milligrams of proteins 
required for future structural determination studies. 
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4.3.1 Solubilisation of the inner membrane bound OafA and GtrCBTP1  
For soluble proteins, isolation by immobilised metal affinity chromatography (IMAC) with 
sufficient washing would remove all other unwanted proteins, giving a very pure sample of 
correctly folded proteins that is necessary for the accuracy of future biochemical and biophysical 
studies. However, this is not sufficient for membrane proteins such as OafA and GtrCBTP1 due to 
the fact that they are bound onto the membrane. Hence, the liberation of these membrane 
proteins from the membrane is necessary before the purification by IMAC to ensure the purity 
of these proteins.  
Detergent based solubilisation is a method of liberating these membrane proteins from the 
lipids that make up the membrane and is shown on Figure 4.3.1. Every detergent molecule 
possesses a hydrophilic head and a hydrophobic tail, allowing it to mimic the lipid molecules that 
make up membranes. At a high enough detergent concentration, these detergent molecules 
group together to form detergent micelles. The minimum concentration of detergent required 
for these micelles to form is the critical micellar concentration (cmc). Micelles are particularly 
important for the purification of membrane proteins as detergents in the micellar form are 
required for the solubilisation of these proteins while keeping the folding of these proteins. 
Hence, a concentration of detergents above the cmc is required for the successful liberation of 
membrane proteins (Seddon et al., 2004). Different detergent molecules have different cmc 
values. Environmental factors such as pH levels, temperature and the presence of other 
molecules could also affect the cmc value of a specific detergent (le Maire et al., 2000).  
Detergents can be classified as ionic, non-ionic, zwitterionic and bile acid salts. Depending on 
the nature of the membrane proteins, different detergents are more effective in liberating 
different membrane proteins. Hence, a detergent solubility test should be performed using 
different detergents to determine which are the most appropriate for solubilisation of these 
proteins.  
OafA and GtrCBTP1 were initially solubilised with 0.5% (w/v) n-dodecyl β-D-maltoside (DDM), a 
mild, non-ionic detergent with a cmc of 0.18mM (0.0009% w/v) in water (Privé, 2007) and a 
micellar molecular weight of approximately 60 kDa (VanAken et al., 1985). 
Figure 4.3.2 depicts the western analyses (Figure 4.3.2(a) and (c)) and corresponding coomassie 
stained gels (Figure 4.3.2(b) and (d)) of the DDM based solubilisation of OafA and GtrCBTP1 
between lanes 1 to 5 and the purification of these proteins by IMAC. The latter will be discussed 
in Section 4.3.2. 
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Figure 4.3.1. Detergent based Solubilisation of Membrane Proteins. Refer to text for explanation. 
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Figure 4.3.2. Western Analyses of the DDM Solubilisation and HisTrap™ Purification of (a) OafA 
and (c) GtrCBTP1 and their respective coomassie stained gels, (b) and (d). M = Protein marker, 
Lane 1 = Vesicles isolated from cultures of expression host, Lane 2 = Soluble fraction after 
detergent solubilisation, Lane 3 = Insoluble fraction after detergent solubilisation, Lane 4 = 
HisTrap™ column flow through, Lane 5 = HisTrap™ column wash through, Lane 6 = Elution 
fraction 1, Lane 7 = Elution fraction 2, Lane 8 = Elution fraction 3. SDS-PAGE was performed with 
a 12% SDS-PAGE gel, under denaturing and reducing conditions.  
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To determine the level of solubilisation of OafA and GtrCBTP1 by DDM, the sample of proteins 
without DDM, the soluble fraction and insoluble fraction after DDM solubilisation were analysed 
as shown on lanes 1, 2 and 3 respectively. If the membrane proteins were successfully liberated 
from the lipid bilayer of the membrane, they would appear in the soluble fractions or lane 2 on 
Figure 4.3.2. This was indeed observed on the western analyses of the solubilisation of OafA and 
GtrCBTP1 shown on Figures 4.3.2(a) and (c) with a signal most likely representing these proteins 
of interest appearing in the soluble fraction on lane 2 with a complete absence of these proteins 
in the insoluble fraction shown on lane 3. The coomassie stained gels shown on Figure 4.3.2(b) 
and (d) also revealed that DDM was successful in the liberation of almost all of the membrane 
proteins with very few lightly visible bands observed in the insoluble fractions. Due to the highly 
successful solubilisation of both OafA and GtrCBTP1 by 0.5% (w/v) DDM, future solubilisation of 
both proteins would be carried out with 0.5% (w/v) DDM. 
4.3.2 Purification of OafA and GtrCBTP1 by immobilised metal affinity chromatography (IMAC) – 
HisTrap™ nickel affinity column. 
After detergent solubilisation, the proteins of interest would be purified by IMAC. This involves 
the interaction of the histidine side chain of the affixed His tag to metal ions with the valency of 
2 (2+) bound to immobile beads in a column or magnetic beads. Every metal ion is able to bind 
to two histidine side chains. Therefore, the longer the His tag, the stronger the protein will bind 
to the beads. However, the His tag should not be excessively long due to the possibility that it 
would affect the folding and function of the protein. OafA and GtrCBTP1 were expressed with a c-
terminal deca-His tag which should sufficiently bind onto the metal affinity beads for purification 
by IMAC. The principle behind nickel affinity purification is depicted on Figure 4.3.3. 
IMAC purification was performed using the GE Healthcare Life Sciences HisTrap™ HP column 
which contains sepharose beads which were loaded with Nickel ions (Ni2+) for His tag protein 
purification. Protein from the soluble fraction of the DDM solubilisation performed as 
mentioned in Section 4.3.1 were loaded on to the column. Sufficient washes were performed to 
remove as much proteins as possible and the bound proteins were eluted off with an elution 
buffer containing a high concentration of imidazole (Materials and Methods Section 2.9.2). 
Three consecutive 1 mL fractions were collected and western analyses of these fractions were 
performed as shown on lanes 6, 7 and 8 of Figure 4.3.2 with the first collected 1 mL fraction 
being represented by lane 6, second by lane 7 and the final fraction by lane 8. In addition, the 
flow through from the loading of the soluble fraction from the DDM solubilisation and the wash 
were also analysed and are depicted on lanes 4 and 5 respectively on Figure 4.3.2.    
The western analyses of the flow and wash of the HisTrap™ purification of OafA and GtrCBTP1 
shown on lanes 4 and 5 of Figure 4.3.2(a) and (c) suggests that the proteins of interest are not 
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present and hence, the interactions of the His tag of the expressed proteins is sufficient to bind 
these proteins to the HisTrap™ column while losing a negligible amount. Future protein 
purification experiments would be carried out using the HisTrap™ purification system charged 
with Ni2+ ions. 
Lanes 6 and 7 of both the western analyses and coomassie stained gels of Figure 4.3.2 for the 
purification of both proteins showed an intense signal and significant coomassie staining for 
what are predicted to be OafA and GtrCBTP1. Additional western signals and coomassie stained 
bands were present on all lane 7 and lane 6 for the purification of GtrCBTP1 at approximately 250 
kDa and a group of bands between 25 and 37 kDa. The group of bands between 25 kDa and 37 
kDa would most likely represent amino acid fragments from the degradation of these proteins 
and the higher molecular weight bands may represent a form of protein aggregation.  
The final elution fraction shown on lane 8 produced a weak signal on the western analyses for 
both proteins while producing a very faint coomassie stained band for GtrCBTP1 and no staining 
for OafA. These information suggest that all proteins were successfully eluted within the 3 mL 
of elution buffer used.  
The results from the purification of OafA and GtrCBTP1 using the HisTrap™ column and the elution 
buffer suggests that this is a method to sufficiently purify and concentrate these proteins. 
However, the presence of protein aggregates and fragments would need to be overcome as 
future biochemical and biophysical experiments would require pure proteins in their native 
form.  
4.3.3 Purification of OafA and GtrCBTP1 by size exclusion chromatography (SEC) 
Protein purification by IMAC is sufficient to separate the proteins of interest from almost all of 
the native proteins of the host strain. However, as observed in Section 4.3.2, it is insufficient to 
separate the aggregates and amino acid fragments from degraded proteins of interest. 
In addition, native high histidine content proteins like ZitB as mentioned in Section 4.1.1 might 
also have be co-purified along with the proteins of interest. Hence, another purification step is 
required to isolate the solubilised proteins of interest from the aggregates, fragments and native 
high histidine content proteins.   
Size exclusion chromatography (SEC) is a method where proteins are separated according to the 
various molecular weights. Gel filtration is one form of SEC that is commonly used in the further 
purification of proteins. This method involves the filtration of the proteins using beads that 
possess pores which are able to allow passage for proteins up to a certain molecular weight. 
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Figure 4.3.3. Binding of the His Tag to Ni2+ during Immobilised Metal Affinity Chromatography 
(IMAC). Refer to text for explanation. Diagram was designed using Microsoft PowerPoint 2013. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.4. Principle of Size Exclusion Chromatography (SEC) by Gel Filtration. Refer to text 
for explanation. Diagram was designed using Microsoft PowerPoint 2013. 
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Proteins which are too big to fit through these pores travel straight down and are isolated in the 
initial few fractions. The smaller the protein, the more likely they will enter these pores and 
hence, travel a further distance down the gel filtration column. As a result, proteins with the 
biggest molecular weights and also protein aggregates will appear first, then possibly the 
proteins of interest and finally, the fragments from the degradation. 
Presence of proteins in these fractions is measured by absorbance units at a wavelength of 280 
nanometers (nm) (A280). The detector that is used to measure these absorbance units detects 
the presence of tryptophan, tyrosine and to a smaller extent, phenylalanine groups on the 
proteins of interest. Therefore, the more proteins in the fraction will produce a larger A280 value. 
The A280 value measured can also be used to calculate the concentration of proteins within the 
fraction if their various extinction coefficients are known. Extinction coefficients can be 
calculated using the following equation (Gill and Von Hippel, 1989), 
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 (𝑀−1𝑐𝑚−1)
= (𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑟𝑦𝑝𝑡𝑜𝑝ℎ𝑎𝑛 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 × 5960)
+ (𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑡𝑦𝑟𝑜𝑠𝑖𝑛𝑒 𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 × 1280)  
IMAC should concentrate these proteins of interest in the eluates as seen in Figures 4.3.2(b)   
and (d) if sufficient amounts of proteins were produced. Hence, the fractions containing the 
proteins of interest should produce the highest absorbance values if the proteins are not phenyl 
group amino acid deficient. OafA and GtrCBTP1 have extinction coefficients of 124680 M-1cm-1 
and 121130 M-1cm-1 respectively. The purification steps mentioned in the following sections 
were performed using the GE Life Sciences S200 26/60 Prep Grade SEC column. Separate 5L 
expression cultures of E. coli MC1061 expressing OafA from pOafA and GtrCBTP1 from pGtrCBTP1 
were prepared. The proteins were solubilised and purified by IMAC using the method mentioned 
in Sections 4.3.1 and 4.3.2. All eluates from IMAC which contained the proteins were loaded 
onto the SEC column and purified. Hence, the final yield of proteins calculated would be per 5L 
cultures of the expression strains prepared. 
4.3.3.1 Purification of OafA by SEC – Gel Filtration 
The SEC A280 trace from the purification of OafA by gel filtration is depicted on Figure 4.3.5(a) 
with the photos of the coomassie stained gels for the analysis of the selected fractions shown 
on Figure 4.3.5(b) and (c).  
A clear strong peak at approximately 200 mAu was observed between samples from Fractions 
30 to 39 as identified by the red arrow shown on Figure 4.3.5(a). These fractions were analysed 
by coomassie staining and the resulting photo was shown on Figure 4.3.5(c). This should 
represent the monomeric form of the solubilised OafA which will be used for future biochemical 
and biophysical analyses which would be performed for the characterisation of this protein. 
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Coomassie stained gels revealed that Fraction 33 possessed the highest concentration of OafA, 
followed by Fraction 34, 32, 35 and 36.  
In addition to the strong peak at approximately 200mAu, there was a presence of a gradual slope 
as identified by the blue arrow on Figure 4.3.5(a) from between Fractions 21 to 29 before the 
steep increase starting from Fraction 30 that made up the 200mAu peak. This identified slope 
might represent protein aggregates of OafA since there is a presence of these proteins in the 
eluates from the IMAC purification as shown in Figure 4.3.2. Slight coomassie staining was 
observed in the lanes representing Fractions 28 and 29 shown on Figure 4.3.5(b) as identified by 
the green arrows. These coomassie stained bands appear at approximately 100 kDa but at much 
lower intensities as compared to the bands observed on lanes representing Fractions 32, 33 and 
34 on Figure 4.3.5(c). These bands do not reappear on the lanes representing proteins within 
Fractions 30 and 39, hence suggesting that the protein aggregates should have been fully 
separated from the monomeric form of OafA. 
Fractions 32 to 36 were pooled together in order to attain the highest yield of OafA possible, 
giving a 25 mL stock of proteins. The concentration of this 25 mL stock of OafA was determined 
using a Nanodrop 1000 which gave an A280 value of 0.091 Au. Using the known extinction 
coefficient and molecular weight of OafA, the concentration of OafA and yield was determined. 
The calculations for the concentration and yield of OafA were performed as follows, 
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝑂𝑎𝑓𝐴 = 124680𝑀−1𝑐𝑚−1   
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑂𝑎𝑓𝐴 = 72391.5𝐷𝑎  
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑂𝑎𝑓𝐴 = 0.091 ÷
124680
72391.5
= 0.0528𝑚𝑔/𝑚𝐿 
∴ 𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑂𝑎𝑓𝐴 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑 𝑝𝑒𝑟 5𝐿 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 = 0.0528 × 25 = 1.32𝑚𝑔 
∴ 𝑌𝑖𝑒𝑙𝑑 𝑜𝑓 𝑂𝑎𝑓𝐴 𝑝𝑒𝑟 1𝐿 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 = 1.32 ÷ 5 = 0.264𝑚𝑔/𝐿 
The overall OafA expression yield of 0.264 mg per litre of culture is considerably lower than 
desired as a few milligrams of pure proteins would be ideal for protein crystallisation trials and 
other biochemical and biophysical experiments.  
The reason for the low yield of OafA is unclear. The coomassie staining analyses of the elution 
fractions containing proteins isolated by IMAC as shown on Figure 4.3.2 revealed that there were 
more purified GtrCBTP1 as compared to OafA as the coomassie stained bands on Figure 4.3.2(d) 
for GtrCBTP1 was considerably more intense than that of OafA. Some form of degradation could 
have occurred prior to IMAC or less OafA was expressed as compared to GtrCBTP1 to begin with. 
To remedy this situation, a larger expression culture volume for E. coli MC1061 expressing OafA 
from the pOafA vector is necessary to attain the appropriate yields of OafA. Concentration using 
a spin column with the PES membrane resulted in precipitation. 
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Figure 4.3.5. Size Exclusion Chromatography (SEC) Trace of the Purification of OafA. 
Absorbance values of each of the fractions collected were measured in milli-absorbance units 
(mAu) as shown in (a). Fractions collected were then analysed by coomassie staining as shown 
in (b) for fractions 21 to 29 and (c) for fractions 30 to 39. Numbers on the top of the coomassie 
stained gel photo represents the fraction number. M = Protein marker. The red arrow was used 
to identify the peak that is thought to represent the protein of interest. The blue arrow was used 
to identify any regions of possible protein aggregation. The black arrow was used to identify 
absorbance peaks that might have been produced as a result of the presence of high 
concentrations of salt in fractions. 
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4.3.3.2 Purification of GtrCBTP1by SEC – Gel Filtration 
As per OafA, the SEC A280 trace from the purification of GtrCBTP1 by gel filtration is depicted on 
Figure 4.3.6(a) with the photos of the coomassie stained gels for the analysis of the selected 
fractions shown on Figure 4.3.6(b) and (c).  
The A280 trace shown on Figure 4.3.6(a) revealed a very strong peak climaxing at slightly above 
700mAu as shown by the red arrow with the peak covering Fractions 30 to 38. These fractions 
were then analysed by protein separation by gel electrophoresis followed by coomassie staining 
as depicted on Figure 4.3.6(c) which showed that the highest concentrations of proteins thought 
to be GtrCBTP1 was in Fraction 32, followed by 33, 31, 34, 35 and 36. Like OafA, a gradual slope 
was observed and identified by the blue arrow on the SEC A280 trace from Fraction 21 until the 
Fraction 30 where a sharp rise in the A280 value begins, forming the sharp peak. This was thought 
to represent the aggregation of the expressed GtrCBTP1 proteins. Analyses of Fractions 21 to 29 
by SDS-PAGE protein separation and coomassie staining was performed and the photo of the 
resulting gel was depicted on Figure 4.3.6(b). Like OafA, very faint bands were observed at 
approximately 100 kDa with respect to the protein marker on lanes representing Fractions 28 
and 29 as pointed out by the green arrows on Figure 4.3.6(b). These bands were also absent on 
the lanes representing Fractions 31 to 36 which would mean that the potential protein 
aggregates of what is thought to be GtrCBTP1 was successfully separated from the monomeric 
form of GtrCBTP1.  
Fractions 31 to 36 were pooled together in order to attain the highest yield of GtrCBTP1. The A280 
value of the resulting 30 mL stock was measured using the Nanodrop 1000 and was determined 
to be 0.325Au. Using the known values of the extinction coefficient and molecular weights of 
GtrCBTP1, the concentration of proteins and yield were determined. 
The calculations were as follows, 
𝐸𝑥𝑡𝑖𝑛𝑐𝑡𝑖𝑜𝑛 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡 𝑜𝑓 𝐺𝑡𝑟𝐶𝐵𝑇𝑃1 = 121130𝑀−1𝑐𝑚−1   
𝑀𝑜𝑙𝑒𝑐𝑢𝑙𝑎𝑟 𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝐺𝑡𝑟𝐶𝐵𝑇𝑃1 = 74132.4𝐷𝑎  
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝐺𝑡𝑟𝐶𝐵𝑇𝑃1 = 0.325 ÷
121130
74132.4
= 0.1989𝑚𝑔/𝑚𝐿 
∴ 𝑇𝑜𝑡𝑎𝑙 𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝐺𝑡𝑟𝐶𝐵𝑇𝑃1 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑒𝑑 𝑝𝑒𝑟 5𝐿 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 = 0.1989 × 30 = 5.967𝑚𝑔 
∴ 𝑌𝑖𝑒𝑙𝑑 𝑜𝑓 𝐺𝑡𝑟𝐶𝐵𝑇𝑃1 𝑝𝑒𝑟 1𝐿 𝑐𝑢𝑙𝑡𝑢𝑟𝑒 = 5.967 ÷ 5 = 1.1934𝑚𝑔/𝐿 
As compared to OafA, the yield per litre of expression cultures of E. coli MC1061 expressing 
GtrCBTP1 from pGtrCBTP1 was approximately 4.5 folds higher. Even though the yield of GtrCBTP1 is 
higher than that of OafA, it is still a relatively lower than needed for extensive biochemical and 
biophysical characterisation. A larger expression culture volume of E. coli MC1061 would still be 
preferred to attain a higher yield prior to biochemical and biophysical experiments. Like for 
OafA, concentration using a spin column with the PES membrane resulted in precipitation.  
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Figure 4.3.6. Size Exclusion Chromatography (SEC) Trace of the Purification of GtrCBTP1. 
Absorbance values of each of the fractions collected were measured in milli-absorbance units 
(mAu) as shown in (a). Fractions collected were then analysed by coomassie staining as shown 
in (b) for fractions 21 to 29 and (c) for fractions 30 to 38. Numbers on the top of the coomassie 
stained gel photo represents the fraction number. M = Protein marker. The red arrow was used 
to identify the peak that is thought to represent the protein of interest. The blue arrow was used 
to identify any regions of possible protein aggregation. The black arrow was used to identify 
absorbance peaks that might have been produced as a result of the presence of high 
concentrations of salt in fractions. 
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4.4 Chapter 4 Conclusion  
From the results discussed in the sections within Chapter 4, it was concluded that the method 
used for the expression and purification of both OafA and GtrCBTP1 was sufficient to attain pure 
samples of both proteins. However, the nature of these proteins affects the overall yield of 
proteins attained from the expression cultures negatively with an achieved maximum protein 
yield of 1.2 mg/L. Larger culture volumes of E. coli MC1061 expressing OafA from the pOafA 
vector and GtrCBTP1 from the pGtrCBTP1 vector should be prepared for future expression and 
purification of these proteins. 
Further expression optimisation could also be performed using more appropriate host strains 
such as E. coli C41 and C43 which were determined to be more successful at over-expressing 
membrane proteins due to the ability to produce membrane proteins as inclusion bodies at 
higher levels than common E. coli expression strains like E. coli BL21(DE3) without the toxicity 
(Miroux and Walker, 1996). These strains are able to consume L-arabinose due to the absence 
of the mutations necessary for the absence of arabinose metabolism. Hence, the optimisation 
experiments as mentioned in Section 4.2.2 would need to be repeated for all concentrations of 
L-arabinose, the duration and temperatures at which induction of protein expression is 
performed. 
Due to the success of solubilisation of OafA and GtrCBTP1 using DDM based detergent 
solubilisation as seen in Section 4.3.1, no solubilisation optimisation is required to be performed. 
Purification of both proteins of interest by IMAC using the HisTrap™ column followed by SEC 
were also successful in attaining a highly pure sample of proteins which would be useful in any 
downstream biochemical and biophysical protein characterisation analyses.  
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Chapter 5 Introduction 
The SGNH hydrolase family of domains are divergent from the classical GDSL family of serine 
lipases and esterases. One difference between these proteins is the position of the catalytic 
residues (i.e. serine, aspartate and histidine) which serine esterases are known to possess. While 
GDSL lipases have a large number of amino acids separating each of the catalytic resides, SGNH 
hydrolases notably have only a maximum of 2 amino acids separating the aspartate and histidine 
residues. 
The role of these catalytic residues from the current literature were previously mentioned in 
Section 3.2. Here, the importance of these catalytic residues will be further discussed and 
suggesting how it might affect the function of OafA and GtrCBTP1. 
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5.1 Analyses of the Catalytic Residues of GtrCBTP1 and OafA 
5.1.1 Hypotheses for the replacement of the putative catalytic amino acids of OafA and GtrCBTP1 
As discussed in Chapter 3, OafA and GtrCBTP1 are thought to possess two domains with the N-
terminal half being a member of the MBOAT family of O-acetyltransferases and the periplasmic 
C-terminal half being an SGNH hydrolase protein.  
SGNH hydrolase type esterases possesses the serine esterase catalytic triad of serine, aspartate 
and histidine. The catalytic aspartate and histidine residues of SGNH hydrolase enzymes are 
found within three amino acids from one another (i.e. DXXH). Through bioinformatical analyses, 
OafA and GtrCBTP1 were hypothesised to possess the SGNH hydrolase type catalytic triad in their 
respective C-terminal periplasmic regions. The predicted structures of the respective C-terminal 
tails of both OafA and GtrCBTP1 were depicted along with the positions of the putative catalytic 
residues on Figure 3.4.1(a) and (b) respectively. 
To assess the importance of the potentially catalytic amino acid residues of OafA and GtrCBTP1, 
the catalytic residues in question were replaced with alanine and the enzymatic functions were 
assessed via in vivo studies.  
Due to the presence of these characteristic SGNH hydrolase type catalytic amino acids, it is 
thought that these replacement mutations would abrogate the functions of these proteins.  
5.1.2 Catalytic residues of GtrCBTP1 
5.1.2.1 Replacement mutations of the putative catalytic residues of GtrCBTP1  
The putative catalytic residues of GtrCBTP1 were individually replaced with alanine to produce 
mutants with the S430A, D618A and H621A mutations separately. This was performed by site 
directed mutagenesis of pGtrCBTP1 [pMV434] using the protocol described in Section 2.6. Hence, 
like the wild-type expressed GtrCBTP1 protein expressed and purified as mentioned in Chapter 4, 
the mutant GtrCBTP1 products would also possess a deca-his tag which would be useful in 
determining if the proteins were being expressed and in the future, could be used to express 
and purify these mutant proteins for biochemical or biophysical analyses. Resulting vectors of 
pBADcLIC expressing GtrCBTP1 possessing the abovementioned mutations will henceforth be 
referred to as pGtrCBTP1(S430A) [pMV437], pGtrCBTP1(D618A) [pMV438] and pGtrCBTP1(H621A) 
[pMV439]. The sequences were confirmed by sequencing (Section 2.4.7.3). 
5.1.2.2 Functional analyses of GtrCBTP1with catalytic residue replacement mutations    
As mentioned in the introduction, GtrCBTP1 acetylates the rhamnose residues of the LPS O-
antigen of S. Typhimurium D23580, hence protecting the bacteria from bacteriophage 
associated death by the phage BTP1. This modification enzyme originates from the BTP1 phage 
and is thought to be present in the bacteria to stop superinfection by blocking the BTP1 tail spike 
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Figure 5.1.2.1 Phage Plaque Assay. See text for details.  
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protein endorhamnosidase activity (Kintz et al., 2015). In order to assess the functionality of the 
GtrCBTP1 proteins with the mutations mentioned in Section 5.1.2.1, an in vivo assay called the 
phage plaque assay was performed. This involves the addition of a small aliquot of 
bacteriophage onto LB agar containing the test bacteria layered on an LB agar plate as shown 
on Figure 5.1.2.1 and mentioned in Section 2.7. 
The introduced bacteriophage would cause lysis of bacteria in a localised area of the layer of LB 
agar, identified by a clear area on the LB agar layer and the formation of plaques which are 
colonies of bacteria which would have gained resistance to the phage. Test bacterial strains 
which are resistant to phage infection would grow normally despite the presence of the 
bacteriophage and hence, no clear area on the LB agar layer would be observed. 
The mutant GtrCBTP1 proteins with either the S430A, D618A or H621A mutations were expressed 
separately in S. Typhimurium LT2 which does not possess a native LPS O-antigen rhamnose 
modifying enzyme but possesses the necessary O-antigen substrate for GtrCBTP1 activity. Along 
with the mutant GtrCBTP1 proteins, the wild type GtrCBTP1 protein from pGtrCBTP1 was also 
expressed in S. Typhimurium LT2 to test for the function of GtrCBTP1 with a deca-his tagged C-
terminal end that is expressed from the pBADcLIC vector. The clones were induced in liquid 
cultures overnight (approximately 19 hours) at the optimised expression conditions (0.01% w/v 
L-arabinose induction at 30°C) for the expression and purification of the wild type GtrCBTP1 
proteins mentioned in Chapter 4.  
To determine if the overnight cultures have produced the proteins, a western and coomassie 
analysis was performed and the results were depicted on Figure 5.1.2.2(a) and (b) respectively. 
The western analyses of the overnight cultures of S. Typhimurium LT2 expressing the wild type 
GtrCBTP1 and its various mutants revealed that the proteins of interest were indeed expressed in 
all clones, albeit in low amounts for that which was expressing the wild type and the mutants 
possessing the S430A and D618A replacements as shown by the red arrows in their respective 
lanes. The photo of the corresponding coomassie stained duplicate gel shown on Figure 
5.1.2.2(b) showed that sufficient amount of proteins were loaded into the gel and hence, should 
produce more intense signals if the expression of these proteins in S. Typhimurium LT2 were 
comparable to the expression levels of the wild type GtrCBTP1 in E. coli as seen in Figure 4.2.3 and 
4.2.4. Hence, expression of these proteins in S. Typhimurium LT2 was likely affected by a host 
strain characteristic. One likely reason for this could be the S. Typhimurium LT2 consumes 
arabinose at a faster rate than the E. coli expression strains utilised as mentioned in Section 4.2.2 
due to the presence of the enzymes involved in the metabolism of arabinose. As the western 
and coomassie analyses for the expression of GtrCBTP1 and its mutant variants from the various 
clones were performed concurrently with the phage plaque assay, the low concentration of 
protein products in the overnight cultures were not known when the latter was performed. 
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Figure 5.1.2.2 Western Analyses of S. Typhimurium LT2 Expressing GtrCBTP1 and its Mutant 
Variants. Performed to determine if the mentioned proteins are expressed in the overnight 
culture prior to addition into the LB agar for BTP1 phage plaque assay. (a) Western analyses 
using the anti-tetra his primary antibody and (b) coomassie staining of the soluble (Sol) and 
insoluble (Ins) fractions from the cell lysates of S. Typhimurium LT2 expressing GtrCBTP1 from 
pGtrCBTP1, GtrCBTP1S430A from pGtrCBTP1(S430A), GtrCBTP1 D618A from pGtrCBTP1(D618A) and 
GtrCBTP1 H621A from pGtrCBTP1(H621A) along with the total protein sample from the cell lysates 
of their respective non – induced cultures (NI). M = protein standard marker. The red arrows in 
(a) identifies the signals which are thought to be the proteins of interest. Protein separation was 
performed with a 12% SDS-PAGE gel, under denaturing and reducing conditions.   
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Control Strains: 
 
 
 
 
 
 
 
Figure 5.1.2.3. BTP1 Phage Plaque Assay for the Functional Analysis of Mutant GtrCBTP1 Proteins. S. Typhimurium LT2 strains expressing the GtrCBTP1 mutants 
possessing the (a) S430A, (b) D618A and (c) H621A replacement mutations. The negative controls with respect to BTP1 phage activity that were included were (d) 
S. Typhimurium D23580, possessing a native GtrCBTP1 and (e) S. Typhimurium LT2 pGtrCBTP1 expressing the wild-type GtrCBTP1. The positive controls with respect to 
BTP1 phage activity include (f) S. Typhimurium LT2, parental strain for the test strains and (g) S. Typhimurium LT2 pGtrCBTP1 vector but no inducer was added for the 
expression of the wild-type GtrCBTP1 proteins. Dilutions of the phage stock were performed in 10-folds (i.e. 100, 10-1, 10-2, 10-3, 10-4, 10-5, 10-6 and 10-7) and the various 
spots where the aliquots were placed were identified by the black arrows. The LB agar in plates for (a), (b), (c) and (e) were supplemented with 0.01% L-arabinose.  
(d) (e) (f) (g) 
(a) (b) (c) 
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In addition to protein expression level analyses, the comparison of the fold of the expressed 
proteins were performed using the results of the western analyses by looking at where their 
respective signals are with respect to the protein marker. No significant changes were observed 
between the wild type and the mutant proteins which could have led to a shift in the position of 
the signal with respect to the protein marker. However, this method would only detect 
significant changes in protein folding which would affect the interactions of the membrane 
protein with the detergent in the SDS-PAGE gel (Rath et al., 2009). Structurally minor but 
functionally significant changes might not be detected in the shift in signal position with respect 
to the protein marker. A more definitive method of determining structural changes such as 
circular dichroism would require pure protein samples which would prove to be cumbersome to 
produce due to the complex membrane protein purification procedures. 
The induced overnight cultures were then added to molten LB agar with the inducer forming a 
mixture which was then layered on a prepared LB agar plate, also containing the inducer. Small 
aliquots of BTP1 phage in various dilutions were added in spots on the layer of LB agar containing 
the different induced overnight cultures. The resulting LB agar plates were incubated overnight 
and the results were depicted on Figure 5.1.2.3. The results from the BTP1 phage plaque assay 
is depicted on Figure 5.1.2.3. The BTP1 phage stocks were able to infect susceptible S. 
Typhimurium strains as shown by the positive control in the form of S. Typhimurium D23580 
(Figure 5.1.2.3(d)) and the negative control in the form of S. Typhimurium LT2 (Figure 5.1.2.3(f)) 
with respect to BTP1 phage activity. The control in the form of S. Typhimurium LT2 pGtrCBTP1 was 
performed to determine if the GtrCBTP1 expressed from the pBADcLIC vector is sufficient in 
protecting the initially susceptible S. Typhimurium LT2 strain against BTP1 phage associated 
killing. As shown in Figure 5.1.2.3(e) for the induced and Figure 5.1.2.3(g) for the uninduced 
cultures of S. Typhimurium LT2 pGtrCBTP1, the expressed GtrCBTP1 seemed to have been sufficient 
for the acetylation of rhamnose and hence, protection against BTP1 phage associated lysis at 
phage dilutions of 10-2 and lower of the initial stock despite the low expression levels seen in the 
western analyses (Figure 5.1.2.2(a)). This suggests that the expression of the mutant proteins in 
S. Typhimurium LT2 should be sufficient in the protection of the host strain from BTP1 phage 
associated lysis if the mutant GtrCBTP1 is able to function despite the mutations introduced.  
Results from the phage assays performed for the S. Typhimurium LT2 strains expressing all three 
mutant proteins from their respective vectors mentioned above were depicted in Figure 
5.1.2.3(a), (b) and (c) for GtrCBTP1 S430A, GtrCBTP1 D618A and GtrCBTP1 H621A respectively. All 
three mutant GtrCBTP1 proteins were not able to protect the host strain from BTP1 phage 
associated lysis, unlike the wild type GtrCBTP1 protein, as significant plaque formation were seen 
throughout all dilutions of the phage stocks, like that of the positive controls. The results of the 
BTP1 phage plaque assay qualitatively suggests that a functional from of GtrCBTP1 can be 
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expressed from the pBADcLIC vector and single replacement mutations for the catalytic triad 
are sufficient to stop the function of GtrCBTP1.  
5.1.3 Catalytic residues of OafA 
Due to the lack of time, the investigation into the importance of the putative catalytic residues 
in Ser412, Asp587 and His590 of OafA was not be performed. However, if given time, the 
mutagenesis of the mentioned catalytic residues of OafA would closely follow that of GtrCBTP1 
and also assessed using an in vivo based method. Plasmid vectors from which OafA and its 
mutants are expressed, would be complemented into an S. Typhimurium strain which was 
engineered to not express OafA. Unlike GtrCBTP1, there are no phage assays for the assessment 
of OafA protein activity. However, another in vivo experiment is available for assessment of OafA 
activity. This involves the expression of the various proteins in the S. Typhimurium strain and 
isolate the LPS of the bacteria which would be tested for the presence of the modification by 
western analyses using the anti-O:5 primary antibody.    
5.2 Catalytic Triads of Other SGNH Hydrolase type Esterase Proteins 
To date, the catalytic triad of a number of SGNH hydrolase proteins have been analysed either 
biochemically using mutagenesis and protein activity assays or biophysically by crystallisation. 
In the following sections, functional studies of the catalytic residues of a selection of these 
proteins would be discussed in order to compare with the results of the mutation of the catalytic 
residues GtrCBTP1 and hypothesise possible outcomes of the future experiment involving the 
replacement mutations of the catalytic triad of OafA.  
5.2.1 Escherichia coli - thioesterase I/protease I/phospholipase L1 (TAP) 
TAP is a multifunctional protein of E. coli with multiple lipase and esterase functions. 
Crystallisation of this protein revealed an SGNH hydrolase fold (PDB: 1IVN) with the relative 
positions of the catalytic residues of serine at amino acid position 10, histidine at position 157 
and aspartate at position 154 as shown in Figure 5.2.1(a) (Lee et al., 2006).  
To assess the importance of these catalytic residues, Lee et al. (2006) first performed amino acid 
replacement mutations on these residues by substituting these residues with alanine (i.e. S10A, 
H157A and D154A). These mutant proteins were expressed, purified and the protein activities 
were tested using an esterase-activity assay. The proteins with the S10A and H157A mutations 
resulted in a retainment of only 0.57% and 0.09% of activity respectively as compared to that of 
the wild type. The mutant protein with the D154A mutation retained 18% of the activity. Circular 
dichroism of these proteins suggest that no structural changes were present as a result of the 
amino acid replacements. Hence, the loss in activity would most likely be attributed to the amino 
acid substitutions. 
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Figure 5.2.1. Crystal structure of (a) thioesterase I/protease I/phospholipase L1 (TAP) of E. coli (PDB: 1IVN), and (b) NanS of E. coli O157:H7 (PDB: 3PT5). α-helices 
are coloured in dark green, β-strands are coloured blue and coils are coloured orange. Amino acids of catalytic triads are identified by crosses; black crosses are for 
amino acids that are found on coils and the white crosses are for amino acids that are found on the α-helices and β-strands. Amino acid names and positions are 
also included with their respective crosses. 
(a) (b) 
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5.2.2 E. coli O157:H7 - NanS (YjhS) 
Sialic acid is a common molecule expressed on the surface of eukaryotic cells and possesses 
multiple functions. As a method of protection, E. coli O157:H7 and some other bacterial 
pathogens also express sialic acid in the capsular polysaccharide (CPS) or lipopolysaccharide 
(LPS) as a method to evade the immune system(Severi et al., 2007). Some of these bacteria are 
also able to catabolise the abundant sialic acid found in the host environment (Vimr and 
Lichtensteiger, 2002, Almagro-Moreno and Boyd, 2009) using enzymatic processes including the 
enzyme NanS, which deacetylates 9-O-sialic acid esterase(Steenbergen et al., 2009). 
The structure of NanS was determined and analysed (PDB: 3PT5) and was found to possess an 
SGNH hydrolase type esterase fold as shown in Figure 5.2.1(b) (Rangarajan et al., 2011). 
However, unlike the E. coli TAP protein and most other SGNH hydrolase proteins, NanS only 
possesses two out of the three catalytic residues of the serine esterase in Ser19 and His301.   
Rangarajan et al. (2011) generated mutant NanS proteins with S19A and H301N replacement 
mutations separately and tested their enzymatic activity using an esterase activity. Both mutant 
NanS proteins were not able to retain any esterase activity as compared to the wild type 
proteins. The absence in protein activity would most likely be attributed to the mutations 
introduced to the protein as the analyses of the tested proteins by dynamic light scattering, 
native gel analysis and circular dichroism revealed that these mutant proteins most likely 
possess the native fold of NanS and were in the monomeric form. 
5.2.3 Pseudomonas aeruginosa - AlgX and AlgJ 
Alginate is an exopolysaccharide that is excreted by P. aeruginosa to form biofilms in the lungs 
of cystic fibrosis patients for protection against environmental stresses and the host immune 
system (Simpson et al., 1988, Pedersen et al., 1990). Alginate can be modified by O-acetylation 
to produce a more stable biofilm matrix as compared to that of the non-O-acetylated alginate 
(Nivens et al., 2001). As mentioned in Section 3.2.4.2, there are two periplasmic proteins that 
are thought to cause the acetylation of alginate, namely AlgX and AlgJ. These proteins were 
analysed structurally and biochemically to understand their various functions better.  
The structure of AlgX from P. aeruginosa PAO1 was determined to possess an SGNH hydrolase 
domain and a carbohydrate binding domain (PDB: 4KNC) as shown on Figure 5.2.2(a). The serine 
esterase catalytic triad of the SGNH hydrolase domain was identified at Ser269, His176 and 
Asp174 (Riley et al., 2013).  To assess the importance of these catalytic residues, separate 
alanine replacement mutations were performed on these potentially catalytic amino acids (Riley 
et al., 2013). The resulting mutant AlgX possessed either the S269A, H176A or D174A mutations. 
The acetylesterase activity of these mutants were assessed in comparison with the wild type 
AlgX using a fluorometric assay.  
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Figure 5.2.2. Crystal structure of (a) AlgX of P. aeruginosa PAO1 (PDB: 4KNC), and (b) AlgJ of P. putida (PDB: 4O8V). The two domains of AlgX were identified and 
named using either the red or black boxes. α-helices are coloured in dark green, β-strands are coloured blue and coils are coloured orange. Amino acids of catalytic 
triads are identified by crosses; black crosses are for amino acids that are found on coils and the white crosses are for amino acids that are found on the α-helices 
and β-strands. Amino acid names and positions are also included with their respective crosses.  
Ser288 
SGNH Hydrolase Domain Carbohydrate Binding Domain 
(a) (b) 
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The wild type AlgX possessed an activity value of 0.0068 ± 0.00057 μmol min-1 mg-1. The mutant 
AlgX with the D174A mutation had an activity value of 0.00032 ± 0.00028 μmol min-1 mg-1 while 
that with the H176A mutation had an activity value of 0.00027 ± 0.00027 μmol min-1 mg-1 which 
were 4.71% and 0.397% of the wild type AlgX activity respectively. Acetylesterase activity of the 
mutant AlgX with the S269A replacement was absent. Circular dichroism analysis revealed that 
these mutant proteins retained the structure of AlgX despite the various introduced mutations. 
Hence, the decrease or absence of the acetylesterase activity measured would be due to the 
absence of these catalytic amino acids and not structural alterations.  
The identified catalytic residues of P. aeruginosa AlgJ, a functionally similar protein to AlgX but 
without the carbohydrate binding domain, which are Ser288, H192 and D190 were also 
separately replaced by alanine and the mutants were analysed by acetylesterase activity using 
the pseudosubstrate, 3-carboxyumbelliferyl acetate (Baker et al., 2014). However, the esterase 
function for each of the mutant proteins retained approximately 20% of the function as 
compared to the wild type AlgJ. This was significantly more than the respective mutations in 
AlgX as mentioned above. Due to the recalcitrance of P. aeruginosa AlgJ to crystallisation for X-
ray crystallography, the orthologous domain from Pseudomonas putida AlgJ was crystallised in 
its place (PDB: 4O8V) and was depicted on Figure 5.2.2(b) with the corresponding catalytic 
residues.  
5.2.4 Neisseria gonorrhoeae - PatB 
The peptidoglycan layer of bacteria in the cell wall and the various modifications involved are 
essential for their survival (Boneca, 2005). O-acetylation of the peptidoglycan is a common form 
of modification. This process is carried out by different groups of enzymes and in N. 
gonorrhoeae, PatA and PatB are responsible for the modification of the peptidoglycan. 
As mentioned in Section 3.2.4.1, PatA is a member of the membrane bound O-acetyltransferase 
(MBOAT) family of enzymes while PatB is thought to be a member of the SGNH hydrolase type 
esterase family of enzymes.  
The predicted structure of PatB was determined, and for this project was repeated, by using the 
known structure of the SGNH hydrolase type esterase Sacchromyces cerevisiae isoamyl acetate-
hydrolysing esterase (PDB: 3MIL) as a template using SWISS-MODEL server 
(http://swissmodel.expasy.org/) (Arnold et al., 2006, Guex et al., 2009, Kiefer et al., 2009, 
Schwede et al., 2003). The results of the structure prediction of PatB was visualised on the Swiss-
PdbViewer 4.1.0 (Guex and Peitsch, 1997) and depicted on Figure 5.2.3 with the relative 
positions of the putative catalytic residues of the protein.
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Figure 5.2.3. Predicted crystal structure PatB of N. gonorrhoeae. Prediction performed using 
isoamyl acetate-hydrolysing esterase of Sacchromyces cerevisiae (PDB: 3MIL) as a template. α-
helices are coloured in dark green, β-strands are coloured blue and coils are coloured orange. 
Amino acids of predicted catalytic triads are identified by crosses; black crosses are for amino 
acids that are found on coils and the white crosses are for amino acids that are found on the α-
helices. Amino acid names and positions are also included with their respective crosses. 
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The putative catalytic residues of Ser133, Asp302 and His305 were identified (Moynihan and 
Clarke, 2014) and their importance were analysed by separate alanine replacement mutations 
followed by steady state kinetic analysis of the determination of the activity of resulting mutant 
proteins. The activity of the mutant proteins with the S133A or H305A mutations were 
completely abolished while that with the D302A mutation retained 20% of the activity with 
respect to the activity profile of the wild type PatB protein. To ensure that no structural changes 
occurred as a result of the replacement mutations, circular dichroism analysis of the mutants 
were compared to that of the wild type and no changes were observed. Hence, the absence or 
decrease in protein activity was a result of the mutations rather than any structural changes. 
5.3 Conclusion – Serine Esterase Catalytic Triad Analysis of OafA and GtrCBTP1 
The analysis of the serine esterase catalytic triad residues of confirmed or putative SGNH 
hydrolases as discussed in Sections 5.2.1 to 5.2.4 shows that replacing these catalytic serine or 
histidine residues result in the significant abrogation of enzymatic function of the enzyme while 
the effects of replacing the aspartate on the enzymatic function were less impactful. This, along 
with the fact that NanS of E. coli O157:H7 only possesses the catalytic dyad of serine and 
histidine, suggests that the aspartate residue, while potentially important, is not necessary for 
enzymatic function.  
As discussed above and in the introduction, GtrCBTP1 is known to acetylate the rhamnose residue 
of the LPS O-antigen of S. Typhimurium D23580 and hence, protecting the bacteria from BTP1 
phage associated killing. The in vivo phage plaque assay demonstrated that the catalytic triad of 
GtrCBTP1 is essential for the function of the protein in the protection against BTP1 associated 
lysis. The BTP1 phage plaque assay proved to be a useful tool in determining if GtrCBTP1 and its 
mutant variants are able to carry out the primary function or not. If the catalytic triad analysis 
of OafA were to be performed, the results are hypothesised to be consistent to GtrCBTP1 as in 
silico analyses revealed high levels of similarities between these proteins. 
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6.1 Salmonella enterica (subspecies I) Lipopolysaccharide (LPS) O-antigen 
Modifications - OafA and GtrCBTP1 
Gtr family II of the newly identified invasive non-typhoidal Salmonella (iNTS), S. Typhimurium 
D23580, was shown to be an O-antigen acetyltransferase responsible for the addition of an 
acetyl group onto the rhamnose residue of the LPS O-antigen backbone (Erica Kintz, Personal 
Communication). In this strain, the family II gtr operon is found on the BTP1 prophage. Like the 
glucosylation by the family I gtr operon, the acetylation of the rhamnose residue of the S. 
Typhimurium D23580 LPS O-antigen provides protection for the bacteria against BTP1 
bacteriophage infection by blocking the endorhamnosidase activity of the phage tail spike 
protein. GtrCBTP1 was found to share similar properties to a known S. Typhimurium LPS O-antigen 
acetyltransferase, OafA. They were both predicted to have an inner membrane bound domain 
and a periplasmic C-terminal domain which consists of close to half the total number of amino 
acids that make up the proteins. OafA acetylates the abequose residue on the LPS O-antigen of 
S. Typhimurium which gives the O:5 serotype.  
Predicted structural similarities and subtle functional differences between OafA and GtrC family 
II, represented by GtrCBTP1, calls for the need to understand these proteins further and attempt 
to identify the basis for their functional difference. 
6.2 Characterisation of OafA and GtrCBTP1 
As discussed in Chapter 3, in silico analyses of these proteins confirmed that OafA, GtrCBTP1, and 
in fact, other GtrC family II proteins have a similar predicted two domain overall structure of an 
N-terminal inner membrane bound domain and a periplasmic C-terminal domain.  
To further analyse these proteins, their various functional domains were predicted using the 
InterProScan tool (Jones et al., 2014, Hunter et al., 2011). The same results returned for OafA 
and the GtrC family II proteins with functional families identified for each of the two predicted 
domains. The N-terminal inner membrane bound domains were predicted to be an 
acyltransferase 3 (Pfam: PF01757), which is a largely uncharacterised domain family, and the C-
terminal periplasmic domains were predicted to be from the SGNH hydrolase type esterase 
family (SUPERFAMILY: SSF52266). SGNH hydrolase proteins are known to have a distinct α/β/α 
fold and a serine esterase catalytic triad of serine, aspartate and histidine with the latter two 
being characteristically at a maximum of three amino acids apart from one another as shown in 
Figures 3.4.2, 5.1.1 and 5.1.2. The same was predicted for OafA and GtrCBTP1 as shown in Figure 
3.4.1. These findings suggest a myriad of characterisation experiments which could be 
performed to further understand the mechanism behind the function of these proteins. This 
includes ligand and substrate binding experiments, domain complementation experiments, 
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structural characterisation along with multiple other biochemical and biophysical experiments. 
Biochemical and biophysical experiments would require pure samples of these proteins. 
SGNH hydrolase type esterases have a distinct serine esterase catalytic triad as mentioned in 
Chapter 3 and Section 6.2.1 and was predicted to be present in both GtrCBTP1 and OafA. Prior 
studies on various other proteins involved in acetyltransferase or acetylesterase activities have 
suggested that this catalytic triad is necessary for protein function. To determine if these 
catalytic residues are necessary in GtrCBTP1, mutant proteins were engineered and each of them 
possessed either the S430A, D618A or H621A mutations. The function of these proteins were 
tested using the phage plaque assay discussed in Section 5.1.2.2. As shown on Figure 5.2.3(d) to 
(g), the mutant GtrCBTP1 failed to retain the function of the proteins despite the presence of a 
single specific replacement mutation as plaque formation and spots of bacterial lysis were 
observed across all phage dilutions. The results from this study on the catalytic residues of 
GtrCBTP1 were similar to that on other studies performed on other SGNH hydrolase proteins 
mentioned in Sections 5.2.1 to 5.2.4 which suggests that these proteins are very likely to possess 
the SGNH hydrolase domain with the characteristic catalytic triad.  
Various biochemical or biophysical in vitro methods requiring sample of purified proteins were 
utilised in the previous studies on other SGNH hydrolase proteins mentioned in Sections 5.2.1 
to 5.2.4. Due to the fact that the SGNH hydrolase portion of both OafA and GtrCBTP1 is attached 
to a membrane bound O-acetyltransferase domain, performing the more common in vitro 
methods might be more cumbersome. This is because the protein yield from the purification of 
membrane bound proteins is significantly lower than that of soluble proteins. This would require 
additional expression optimisation to increase the yield and detergent tests to find a more 
biochemical analysis friendly detergent. Instead, in vivo strategies like the BTP1 phage plaque 
assay and the LPS analysis by western blotting are available for use to analyse the function of 
the mutant OafA and GtrCBTP1 proteins respectively. Unlike in vitro tests, this allows for a more 
biologically relevant functional analyses of these proteins within a native environment. 
Previous studies also showed that about 20% of the function was retained for the mutant 
proteins possessing the catalytic aspartate replacement mutations. Hence, it was hypothesised 
that GtrCBTP1 possessing the D618A mutations would also retain some functional activity 
especially if lesser amounts of phage is present for infection (i.e. spots with lower concentrations 
of phage). However, the extent of phage activity was similar throughout the S. Typhimurium LT2 
strains expressing each of the three mutant proteins mentioned above. One reason for this could 
be that the phage dilutions were still too high at 10-8 of the original phage stock. Another reason 
for this phenomenon could be that the decreased rhamnose acetylation, if any, were only 
present on a few LPS molecules and not randomly spread out between all LPS molecules. This 
allows the BTP1 phage to perform its endorhamnosidase activity to cleave the unmodified LPS 
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in order to gain access to the cell surface. If the modification was spread out randomly, some 
form of protection against the BTP1 phage endorhamnosidase activity could still be present. 
Finally, unlike the other SGNH hydrolase proteins mentioned in previous studies, Asp618 could 
be essential for the function of GtrCBTP1.      
6.2.1 Putative Mechanism of Action 
With the current understanding of OafA and GtrCBTP1, including findings from this study, it is 
hypothesised that an acetyl group from a source, likely to be acetyl-CoA, would be transported 
from the cytoplasm to the periplasmic C-terminal tail domain via the acyltransferase activity of 
the N-terminal domain. The acetyl group would then be transported to the LPS O-antigen at an 
unknown stage of the LPS biosynthesis via the activity of the serine esterase catalytic triad of 
serine, aspartate and histidine using an unidentified sugar binding motif which contributes to 
the specificity of these proteins (Figure 6.3.1). To date, the addition of the acetyl groups and in 
fact, the glucose to the specific sugar residues occur at an unknown stage of the LPS biosynthesis 
pathway. In addition, it is not definitively known if the modifications occur on all LPS molecules.  
6.3 Future Experiments  
Further analysis would be required in order to determine the complete mechanism of action 
and characteristics of these acetyltransferases. In this section, a few unanswered questions were 
raised and experiments were suggested. 
6.3.1 LPS O-antigen binding sites 
Firstly, the O-antigen binding sites of the proteins are still unknown. One method to determine 
where these sites could be is by extensive search in the current literature for proteins which are 
known to bind to these sugars to determine the common sequential, chemical or structural 
characteristics that could contribute to the sugar binding. Once identified, mutations can be 
performed on the respective sites and the functions of the proteins can be tested using the in 
vivo tests mentioned in Section 5.1. Another method is to narrow down the region of amino acid 
residues which possesses the sugar binding residues by performing a protein domain 
complementation which involves engineering a protein with the N-terminal acyltransferase 3 
domain of either OafA or GtrCBTP1 and the C-terminal SGNH hydrolase domain of the other. The 
function of these hybrid proteins can be tested using the same in vivo tests mentioned in Section 
5.1. If the functions are retained despite having a C terminal domain that is from the other 
protein, the sugar binding site should not be within the SGNH hydrolase C terminal domain. 
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Figure 6.2.1. Proposed mechanism of OafA and GtrCBTP1. A general lipopolysaccharide (LPS) 
biosynthesis pathway is shown using the black arrows with an open head. For both 
acetyltransferases, the acetyl group from an source (suggested as Acetyl-CoA on the diagram) is 
transported through the inner membrane via the membrane bound acyltransferase 3 domain 
and passed through to the periplasmic C-terminal SGNH hydrolase domain. Using the catalytic 
triad within these proteins, the acetyl group is then transported to the specific sugar residues at 
an unknown stage of the LPS biosynthetic pathway as shown by the red and green dashed 
arrows.  
 
 
SGNH 
hydrolase 
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SGNH 
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6.3.2 Serine esterase catalytic residues of OafA 
As mentioned in Chapter 5 and Section 6.2.3, the catalytic triad of GtrCBTP1 were mutated which 
resulted in the loss of protein function. A similar approach to OafA should be taken in order to 
analyse the importance of the putative catalytic residues. Due to the similarities of OafA and 
GtrCBTP1, it was hypothesised that mutating the catalytic residues in OafA using replacement 
mutations would also abolish protein function.  
6.3.3 Biochemical and biophysical analyses of OafA and GtrCBTP1 
Biochemical and biophysical analyses of these proteins of interest would reveal different 
molecular and physical characteristics which would then clarify the underlying functional 
mechanisms of these proteins. Biochemical experiments such as size exclusion chromatography 
with multi angle light scattering (SEC-MALS) (Striegel et al., 2009) for the detection of the 
absolute molecular mass of these proteins (i.e. whether they are monomeric or otherwise) and 
saturation transfer difference nuclear magnetic resonance (STD-NMR) for the identification of 
potential ligands of these proteins can be performed (Viegas et al., 2011). The structure of these 
proteins can also be determined using X-ray crystallography or NMR.  
However, these biochemical and biophysical experiments require pure samples of proteins in 
order to get accurate results. Hence, the expression of OafA and GtrCBTP1 should be further 
optimised based on the current expression conditions mentioned in Chapter 4 in order to get a 
sufficiently high yield of proteins. 
6.3.4 Other GtrC family II proteins    
Among GtrC family II proteins, GtrCBTP1 is the least similar at approximately 77% amino acid 
conservation with each of the rest of the members of the family (Table 3.1.2). Nevertheless, the 
characteristics of GtrCBTP1 should be parallel with that of the other members of the GtrC family 
II. To determine if this holds true, the various proteins within GtrC family II can be complemented 
into the S. Typhimurium LT2 strain and the resulting clones expressing the various proteins can 
be tested using the BTP1 phage assay as per the method mentioned in Section 5.2.1. The 
proteins which provide protection of the S. Typhimurium LT2 strain against BTP1 phage activity 
would suggest that these orthologous proteins are functionally the same and hence, should 
share multiple characteristics with GtrCBTP1. 
 
6.3.5 Oac, LPS acetyltransferase of Shigella flexneri 
Oac is an LPS acetyltransferase form S. flexneri which, like GtrCBTP1, acetylates a rhamnose in the 
LPS (Thanweer and Verma, 2012). However, Oac is only a single domain membrane bound 
protein of the acyltransferase 3 family and hence, does not possess an SGNH hydrolase domain. 
If this modification system utilises a separate periplasmic protein like what PatB is to PatA in 
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Neisseria, it has yet to be identified be it an SGNH hydrolase family protein or of a different 
family. This protein could also be functional on its own unlike the various proteins mentioned in 
this thesis including OafA and GtrCBTP1. 
The diversity in LPS acetyltransferase systems calls for the need to further understand the 
proteins involved and what sets each system or individual proteins apart.   
6.4 Closing Remarks 
Equipped with biologically relevant functional assays, the findings from this project has provided 
a deeper understanding of the structural and functional characteristics of OafA and GtrCBTP1 and 
yet, it has also suggested more experiments which could be perform to build upon the current 
knowledge of these proteins. To date, not much is known about the mechanism of LPS O-antigen 
acetyltransferases, be it in Salmonella or other genus of Gram-negative bacteria. Hence, the 
results from this project and future work could go on to characterising other LPS O-antigen 
acetyltransferases and perhaps, identify a new family of LPS modification enzymes. 
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